US20200085991A1 - Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources - Google Patents
Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources Download PDFInfo
- Publication number
- US20200085991A1 US20200085991A1 US16/690,784 US201916690784A US2020085991A1 US 20200085991 A1 US20200085991 A1 US 20200085991A1 US 201916690784 A US201916690784 A US 201916690784A US 2020085991 A1 US2020085991 A1 US 2020085991A1
- Authority
- US
- United States
- Prior art keywords
- wound
- color
- anthocyanin
- substrate material
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 title claims abstract description 72
- 235000010208 anthocyanin Nutrition 0.000 title claims abstract description 69
- 229930002877 anthocyanin Natural products 0.000 title claims abstract description 69
- 239000004410 anthocyanin Substances 0.000 title claims abstract description 69
- 150000004636 anthocyanins Chemical class 0.000 title claims abstract description 68
- 235000013311 vegetables Nutrition 0.000 title claims abstract description 20
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 48
- 239000000758 substrate Substances 0.000 claims abstract description 40
- 239000004744 fabric Substances 0.000 claims description 49
- 244000235659 Rubus idaeus Species 0.000 claims description 28
- 229920000742 Cotton Polymers 0.000 claims description 20
- 229940103272 aluminum potassium sulfate Drugs 0.000 claims description 13
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 claims description 13
- 239000000853 adhesive Substances 0.000 claims description 12
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 11
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 11
- 239000004599 antimicrobial Substances 0.000 claims description 11
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 9
- 241001092459 Rubus Species 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 claims description 9
- 244000111388 Rubus occidentalis Species 0.000 claims description 8
- 235000003942 Rubus occidentalis Nutrition 0.000 claims description 8
- 239000002250 absorbent Substances 0.000 claims description 8
- 230000002745 absorbent Effects 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 235000015810 grayleaf red raspberry Nutrition 0.000 claims description 8
- 229940124597 therapeutic agent Drugs 0.000 claims description 8
- 241000132456 Haplocarpha Species 0.000 claims description 6
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 6
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 6
- 241000167854 Bourreria succulenta Species 0.000 claims description 5
- 240000007124 Brassica oleracea Species 0.000 claims description 5
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 5
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 5
- 235000002767 Daucus carota Nutrition 0.000 claims description 5
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims description 5
- 240000001890 Ribes hudsonianum Species 0.000 claims description 5
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 5
- 244000281247 Ribes rubrum Species 0.000 claims description 5
- 235000016911 Ribes sativum Nutrition 0.000 claims description 5
- 235000002355 Ribes spicatum Nutrition 0.000 claims description 5
- 235000016897 Ribes triste Nutrition 0.000 claims description 5
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 5
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 5
- 241000219094 Vitaceae Species 0.000 claims description 5
- 235000021014 blueberries Nutrition 0.000 claims description 5
- 235000019693 cherries Nutrition 0.000 claims description 5
- 235000021021 grapes Nutrition 0.000 claims description 5
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 claims description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 5
- 229920002994 synthetic fiber Polymers 0.000 claims description 5
- 244000178937 Brassica oleracea var. capitata Species 0.000 claims description 4
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 claims description 4
- 235000005206 Hibiscus Nutrition 0.000 claims description 4
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims description 4
- 244000284380 Hibiscus rosa sinensis Species 0.000 claims description 4
- 244000151637 Sambucus canadensis Species 0.000 claims description 4
- 235000018735 Sambucus canadensis Nutrition 0.000 claims description 4
- 235000004976 Solanum vernei Nutrition 0.000 claims description 4
- 241000352057 Solanum vernei Species 0.000 claims description 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 4
- 239000000739 antihistaminic agent Substances 0.000 claims description 4
- 235000007123 blue elder Nutrition 0.000 claims description 4
- 235000007242 delphinidin Nutrition 0.000 claims description 4
- 235000007124 elderberry Nutrition 0.000 claims description 4
- 235000008995 european elder Nutrition 0.000 claims description 4
- 235000009584 malvidin Nutrition 0.000 claims description 4
- 229930015721 peonidin Natural products 0.000 claims description 4
- 235000006404 peonidin Nutrition 0.000 claims description 4
- 229930015717 petunidin Natural products 0.000 claims description 4
- 235000006384 petunidin Nutrition 0.000 claims description 4
- HASVPNDDKSXPGU-MEZDFCMFSA-O Pelargonidin 3-sophoroside Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1c(-c2ccc(O)cc2)[o+]c2c(c(O)cc(O)c2)c1)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HASVPNDDKSXPGU-MEZDFCMFSA-O 0.000 claims description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 3
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000006251 pelargonidin Nutrition 0.000 claims description 3
- HASVPNDDKSXPGU-WGNLCONDSA-O pelargonidin 3-O-sophoroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C=C1 HASVPNDDKSXPGU-WGNLCONDSA-O 0.000 claims description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 3
- 235000011152 sodium sulphate Nutrition 0.000 claims description 3
- 239000012209 synthetic fiber Substances 0.000 claims description 3
- 240000000851 Vaccinium corymbosum Species 0.000 claims 1
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 claims 1
- XVFMGWDSJLBXDZ-UHFFFAOYSA-O pelargonidin Chemical compound C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 XVFMGWDSJLBXDZ-UHFFFAOYSA-O 0.000 claims 1
- XFDQJKDGGOEYPI-UHFFFAOYSA-O peonidin Chemical compound C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 XFDQJKDGGOEYPI-UHFFFAOYSA-O 0.000 claims 1
- AFOLOMGWVXKIQL-UHFFFAOYSA-O petunidin Chemical compound OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 AFOLOMGWVXKIQL-UHFFFAOYSA-O 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 description 165
- 206010052428 Wound Diseases 0.000 description 164
- 239000000975 dye Substances 0.000 description 75
- 230000008859 change Effects 0.000 description 55
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- 239000003086 colorant Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 15
- 239000000049 pigment Substances 0.000 description 14
- 230000035876 healing Effects 0.000 description 12
- 230000036541 health Effects 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 239000000284 extract Substances 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 239000011777 magnesium Substances 0.000 description 9
- 229910052749 magnesium Inorganic materials 0.000 description 9
- 229940091250 magnesium supplement Drugs 0.000 description 9
- 235000021013 raspberries Nutrition 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- 210000000416 exudates and transudate Anatomy 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 230000007935 neutral effect Effects 0.000 description 7
- 235000013995 raspberry juice Nutrition 0.000 description 7
- 108010010803 Gelatin Proteins 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 230000002378 acidificating effect Effects 0.000 description 5
- 229930014669 anthocyanidin Natural products 0.000 description 5
- 235000008758 anthocyanidins Nutrition 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 244000078534 Vaccinium myrtillus Species 0.000 description 4
- 238000000540 analysis of variance Methods 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 4
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 4
- -1 hydroxide ions Chemical class 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 4
- 239000000347 magnesium hydroxide Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 235000012254 magnesium hydroxide Nutrition 0.000 description 3
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 150000008163 sugars Chemical group 0.000 description 3
- 238000011179 visual inspection Methods 0.000 description 3
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 2
- CZWJCQXZZJHHRH-YCRXJPFRSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O CZWJCQXZZJHHRH-YCRXJPFRSA-N 0.000 description 2
- 108010001478 Bacitracin Proteins 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108010093965 Polymyxin B Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 235000007336 cyanidin Nutrition 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 229960001162 dihydrostreptomycin sulfate Drugs 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 150000002338 glycosides Chemical group 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 2
- 229960002064 kanamycin sulfate Drugs 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- 229940053050 neomycin sulfate Drugs 0.000 description 2
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- BWRBVBFLFQKBPT-UHFFFAOYSA-N (2-nitrophenyl)methanol Chemical compound OCC1=CC=CC=C1[N+]([O-])=O BWRBVBFLFQKBPT-UHFFFAOYSA-N 0.000 description 1
- ZEUUPKVZFKBXPW-TWDWGCDDSA-N (2s,3r,4s,5s,6r)-4-amino-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,5s,6r)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N ZEUUPKVZFKBXPW-TWDWGCDDSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- XGAKTAXPHNYSTK-RMIBZTJPSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;hydrochloride Chemical compound Cl.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O XGAKTAXPHNYSTK-RMIBZTJPSA-N 0.000 description 1
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 1
- YWMSSKBMOFPBDM-UHFFFAOYSA-N 4-carbamoylbenzenesulfonyl chloride Chemical compound NC(=O)C1=CC=C(S(Cl)(=O)=O)C=C1 YWMSSKBMOFPBDM-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical class [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241001465805 Nymphalidae Species 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 206010034203 Pectus Carinatum Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 244000157386 Rubus rosifolius Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 235000006650 Syzygium cordatum Nutrition 0.000 description 1
- 240000005334 Syzygium guineense Species 0.000 description 1
- 235000006651 Syzygium guineense Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 0 [1*]C1=C(C2=CC([7*])=C([6*])C([5*])=C2)[O+]=C2C=C([4*])C([3*])=C([2*])C2=C1 Chemical compound [1*]C1=C(C2=CC([7*])=C([6*])C([5*])=C2)[O+]=C2C=C([4*])C([3*])=C([2*])C2=C1 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 229960001656 amikacin sulfate Drugs 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 150000001453 anthocyanidins Chemical group 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 238000011203 antimicrobial therapy Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 229960005364 bacitracin zinc Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- CZPLANDPABRVHX-UHFFFAOYSA-N cascade blue Chemical compound C=1C2=CC=CC=C2C(NCC)=CC=1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 CZPLANDPABRVHX-UHFFFAOYSA-N 0.000 description 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 1
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 description 1
- OIDPCXKPHYRNKH-UHFFFAOYSA-J chrome alum Chemical compound [K]OS(=O)(=O)O[Cr]1OS(=O)(=O)O1 OIDPCXKPHYRNKH-UHFFFAOYSA-J 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Chemical class 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- CFUQBFQTFMOZBK-QUCCMNQESA-N ibazocine Chemical compound C12=CC(O)=CC=C2C[C@H]2N(CC=C(C)C)CC[C@]1(C)C2(C)C CFUQBFQTFMOZBK-QUCCMNQESA-N 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical class II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 150000001457 metallic cations Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229960004832 netilmicin sulfate Drugs 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 229960005065 paromomycin sulfate Drugs 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 229960003548 polymyxin b sulfate Drugs 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000035440 response to pH Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 229960001435 sisomicin sulfate Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 229960004477 tobramycin sulfate Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- UCRLQOPRDMGYOA-DFTDUNEMSA-L zinc;(4r)-4-[[(2s)-2-[[(4r)-2-[(1s,2s)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2s,3s)-1-[[(3s,6r,9s,12r,15s,18r,21s)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carbox Chemical compound [Zn+2].C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC([O-])=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(=O)N[C@H](CC([O-])=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 UCRLQOPRDMGYOA-DFTDUNEMSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/56—Wetness-indicators or colourants
Definitions
- the invention generally relates to wound dressings and their methods of use. More particularly, the invention relates to wound dressings dyed with a pH sensitive dye composition comprising at least one anthocyanin obtained from (e.g., derived from) a fruit or vegetable extract, and methods of using the wound dressings for monitoring wound health.
- a pH sensitive dye composition comprising at least one anthocyanin obtained from (e.g., derived from) a fruit or vegetable extract, and methods of using the wound dressings for monitoring wound health.
- the pH of a wound often signifies important information about wound health. Measuring the pH of a wound can provide information about the stage of healing and the presence of infection.
- the pH of wound leakage has been shown to change as the wound heals and if the wound becomes infected.
- the natural pH of skin is slightly acidic, ranging from 4.8 to 6.0, an adaptation which wards off bacteria on the surface, but the interstitial fluid in the body has a pH closer to neutral (Romanelli, M, et al., 2002).
- pH starts slightly basic, moves to neutral, and then approaches the pH of normal skin (Gethin, G 2007). Healthy wounds usually follow this trend, and it can be problematic if a wound does not. If healing is not progressing, the pH will stay basic.
- Many bacteria produce ammonia, which has a pH of 11.6 in a 1.0 M aqueous solution. Ammonia production raises the pH of a wound and lowers the oxygen availability. With a decreased oxygen supply, a wound will take much longer to heal (Leveen, H. et al., 1973).
- the bacteria present in an infection negatively affect the wound and its oxygen content. Bacteria and other factors can result in long periods of time in which the wound environment is at a basic pH. Because this can slow healing, measures are often taken to lower wound pH. Thus, measuring the pH of a wound can provide information about the stage of healing and the presence of infection.
- the present invention relates to a wound dressing, such as gauze, bandages, and surgical tapes, impregnated with a pH sensitive dye composition comprising an anthocyanin dye.
- this disclosure provides a wound dressing.
- the wound dressing comprising a substrate material and a pH sensitive dye composition disposed within the substrate material and comprising at least one fruit or vegetable derived anthocyanin.
- dressing and wound dressing are used interchangeably and refer to a material applied to a wound to promote healing and/or prevent further harm.
- wound refers to an injury to living tissue caused by a cut, blow, laceration, surgical incision or other impact, typically one in which the skin is cut or broken.
- Types of injures include, for example, cuts, scrapes, scratches, burns, blisters, insect bites, and surgical sites, to name a few.
- this disclosure provides methods for manufacturing a wound dressing, comprising: providing a substrate material; and disposing pH sensitive dye composition comprising at least one fruit or vegetable derived anthocyanin within the substrate material.
- the invention provides wound dressing and methods of use thereof, which utilize a pH sensitive dye composition comprising at least one fruit or vegetable derived anthocyanin.
- a pH sensitive dye composition comprising at least one anthocyanin is derived from a fruit or vegetable selected from the group consisting of a red cabbage, purple cabbage, purple carrots, elderberry, hibiscus, purple potato, red currant, black currants, blueberries, cherries, purple grapes, red raspberries and black raspberries.
- wound dressing and methods of use thereof that use a pH sensitive dye composition utilize a pH sensitive dye composition comprising at least one anthocyanin is derived from red cabbage.
- wound dressing and methods of use thereof that use a pH sensitive dye composition utilize a pH sensitive dye composition comprising at least one anthocyanin is derived from a raspberry ( Rubus sp.).
- at least one anthocyanin is selected from the group consisting of cyaniding-3-sophoraside, cyanide-3-glucoside or pelargonidin-3-sophoroside.
- anthocyanins include anthocyanadin derivatives selected from the group consisting of cyandin, delphinidin, peonidin, petunidin, pelargonidin and malvidin anthocyanadin derivatives.
- the pH sensitive dye composition is sensitive at least within a pH range of pH 4.0 to pH 12.0, inclusive.
- the pH sensitive dye composition comprises a mordant, which are well known to the skilled artisan.
- the pH sensitive dye composition may comprise a mordant selected from the group consisting of aluminum potassium sulfate, copper sulfate, iron (III) oxide, copper sulfate, citric acid, iron (III) sulfate (Fe 2 (SO 4 ) 3 ) and sodium sulfate.
- the mordant is aluminum potassium sulfate.
- the wound dressing may be any dressing suitable for application to the surface of a wound, including, for example an open wound.
- the wound dressing is selected from the group consisting of a pad, wrap, bandage, tape, cotton-tipped stick and adhesive strip bandage.
- the substrate material comprises an absorbent or water-permeable material.
- the absorbent or water-permeable material is capable of absorbing wound exudate. Suitable absorbent materials will preferably absorb at least about 10% by weight, at least about 20% by weight, at least about 30% by weight, at least about 50% by weight, at least about 75% by weight, or at least about 100% by weight of fluid or exudate.
- the dressing can be composed of a substrate material comprising woven materials, non-woven materials or both. In some embodiments, the dressing comprises a fabric, cloth or sponge material. The dressing may be composed of natural and synthetic materials.
- the substrate material comprises cotton material including, cotton fabric or cotton gauze.
- the wound dressing further comprises at least one therapeutic agent selected from the group consisting of antimicrobial agents, antiseptic agents, anti-inflammatory agents, pain relieving agents, wound closing adhesive agents, and antihistamine agents.
- the pH sensitive dye composition provides a clear and obvious indication of wound health.
- the pH sensitive dye composition can provide an indication as to whether an antimicrobial therapy is effective for treating or preventing wound infection.
- this disclosure provides methods for determining the status of a wound, the methods comprising applying a wound dressing on a wound surface, wherein the wound dressing comprises a substrate material, and a pH sensitive dye composition disposed within the substrate material and comprising at least one fruit or vegetable derived anthocyanin; and determining the status of the wound by assessing the color change of the pH sensitive dye composition after application of the dressing onto the wound surface.
- this disclosure provides methods treating a wound comprising: applying a wound dressing to the surface of the wound, wherein the wound dressing comprises a substrate material; and a pH sensitive dye composition disposed within the substrate material and comprising at least one fruit or vegetable derived anthocyanin; assessing the color of the wound dressing after application of the dressing onto the wound surface; and selecting a treatment plan based on the status of the wound based on the color of the wound dressing application to the wound surface.
- assessing the color change of the pH sensitive dye composition comprises monitoring the color change of the dressing over time. Assessing the color change of the pH sensitive dye composition may comprise monitoring the color change of the dressing for a period between 1 to 24 hours, a period of between 2 to 16 hours, a period of between 3 to 12 hours, a period of between 4 to 10 hours, or a period of between 6 to 8 hours after application of the dressing onto the wound surface. Assessing the color change of the pH sensitive dye composition may comprise monitoring the color change of the wound dressing at predetermined time intervals, such as, for example, one hour, two hour, four hour, six hour, eight hour, twelve hour or twenty-four hour time intervals following application of the dressing onto the wound surface.
- the color change of the pH sensitive dye composition may be accomplished using the human eye or with the assistance of a visualization aide.
- assessing the color change of the pH sensitive dye composition can be performed by visual inspection or by using a color-sensing device.
- the color-sensing device is selected from the group consisting of a colorimeter and a spectrometer.
- Assessing the color change of the pH sensitive dye composition can be performed using an imaging device.
- the imaging device is selected from the group consisting of a colorimeter, spectrometer, a digital camera, a mobile phone, a smartphone, a tablet, a portable computer, a computer, and a scanner.
- the methods provided herein further comprising removing or replacing the wound dressing when the color of the wound dressing indicates a basic pH.
- the methods for treating a wound comprise selecting a treatment plan based on the status of the wound.
- the treatment plan can comprise removing or replacing the wound dressing when the color or the wound dressing indicates a basic pH.
- the treatment plan comprises selectively administering one or more therapeutic agents and at least one therapeutic agent selected from the group consisting of antimicrobial agents, antiseptic agents, anti-inflammatory agents, pain relieving agents, wound closing adhesive agents, and antihistamine agents to the wound.
- the term “one or more” includes at least one, more suitably, one, two, three, four, five, ten, twenty, fifty, one-hundred, five-hundred, etc., of the item to which “one or more” refers.
- the term “at least one” as used in the present invention stands for one, two, three, four, five, ten, twenty, fifty, one-hundred, five-hundred, etc., or more of the item “at least one” refers to.
- FIG. 1 is a photograph demonstrating the gradient of colors for raspberry puree at pH 4.0, pH 5.0, pH 6.0, pH 7.0, pH 8.0, and pH 9.0 (top row, left to right: pH 4.0, pH 5.0, pH 6.0; bottom row, left to right: pH 7.0, pH 8.0, pH 9.0).
- FIG. 2 is a photograph showing the bright red color of sample gauze and other medical bandages dyed with raspberry juice in an aluminum potassium sulfate solution without magnesium.
- FIG. 3 are photographs demonstrating the color of dyed fabric before (left hand images) and after (right hand images) pH exposure (pH 5.0 (top row), pH 6.0 (middle row) and pH 7.0 (bottom row)).
- FIG. 4 is a graph demonstrating blue RGB values plotted against red RGB values before and after soaking. Each line represents a pH, connecting the initial Red-Blue point, noted in black, to the final Red-Blue point.
- FIG. 5 is a graph demonstrating blue RGB values plotted against red RGB values before and after pH soaking. Each line represents a pH, connecting the initial Red-Blue point, noted in black, to the final Red-Blue point.
- FIG. 6 is a graph demonstrating blue RGB values plotted against red RGB values before and after bacterial exposure. Each line represents a pH, connecting the initial Red-Blue point to the final Red-Blue point, noted in black.
- the present invention is based, in part, on the discovery that wound dressing materials impregnated with a pH-sensitive dye composition comprising at least one anthocyanin derived from a fruit or vegetable source, including for example an anthocyanin derived from raspberries ( Rubus sp.), can be used on patients with long-term or chronic wounds to detect wound health and infection.
- the disclosure provides wound dressings designed for application to a wound, the wound dressing comprising a substrate material, and a pH sensitive dye composition disposed within the substrate material and comprising at least one anthocyanin dye derived from a fruit or vegetable.
- the wound dressings described herein absorb wound exudate and provide an indication of wound pH, and thus indication of wound health.
- the dressings provided herein provide noninvasive, immediate information about a wound to help individualize treatment.
- the disclosure further provides methods for determining the pH of a wound, comprising contacting the wound with a dressing containing at least one anthocyanin dye derived from a fruit or vegetable; and monitoring the color change of the dressing material to determine the pH of the wound.
- Wound dressings are often integral to wound healing. Wound dressings are prepared in many forms and for many different uses. Generally, a dressing is designed to be in direct contact with the wound and may be used in the form of a wrap or bandage. Aside from the major function of reducing the risk of infection, wound dressings are also important for providing a protective barrier from outside sources of irritation and provide mechanical support to the fragile wound surface. Wound dressings also function to absorb wound byproducts (e.g. excess blood, plasma, or other fluids) that tend to accumulate and complicate healing.
- wound byproducts e.g. excess blood, plasma, or other fluids
- would dressings serve to form an occlusive barrier to provide an optimal environment for certain wound types, and act as an agent for wound debridement, which acts to clean and prepare a wound bed for healing.
- the pH of a wound may be assessed using a wound dressing as disclosed herein, which changes color in dependence upon pH. Such wound pH information may be used to facilitate selection of the appropriate treatment to which the wound should be subjected.
- the wound dressing can be sterilized in an autoclave and loaded with antibacterial/antiseptic agents to provide a wound dressing which will indicate the pH of wound exudates in a non-invasive and simple manner.
- a wound dressing as disclosed herein would be applied to a wound site of a subject with a surface of the wound dressing in contact with a surface of the wound.
- the wound dressing then would be monitored over a predetermined time period to assess the extent of the exudate present in the dressing.
- chromism is a process that induces a reversible change in the colors of compounds. In most cases, chromism is based on a change in the electron states of molecules, so this phenomenon is induced by various external stimuli which can alter the electron density of substances. It is known that there are many natural compounds that have chromism, and many artificial compounds with specific chromism have been synthesized to date. Chromism is classified by what kinds of stimuli are used.
- Color change can occur by changes in electromagnetic radiation, reflection, absorption or scattering.
- photochromism signifies color change triggered by electromagnetic radiation
- thermochromism signifies color change triggered by changes in temperature
- electrochromism signifies changes in color occurring due to gain or loss of electrons
- solvatochromism signifies color change resulting from changes in solvent polarity
- ionochromism signifies color change caused by ions
- piezochromism signifies changes caused by mechanical pressure
- halochromism signifies color change caused by a change in pH.
- Anthocyanins are a class of halochromatic substances which respond to the level of acidity in an environment with a color change (Van der Schueren, L. & De Clerck, K., 2012).
- Anthocyanins pigments are responsible for the red, purple, and blue colors of many fruits and vegetables, including red and purple cabbage, beets, purple carrots, elderberry, hibiscus, purple potato, red and black currants, blueberries, cherries, purple grapes, and red and black raspberries. Within the plant they serve as key antioxidants and pigments contributing to the coloration of flowers.
- Anthocyanin pigment has a color gradient from orange to blue in the visible light spectrum, following the range of possible pH values. In the ultraviolet spectrum, the colors range from browns and yellows to purples and blues.
- the color the anthocyanin molecule displays can change in relation to its environment; it is behind the color transition of green to red leaves from summer to autumn. These pigments are formed inside the plant through a metabolic pathway utilizing phenylalanine. Inside a plant cell, anthocyanins are dissolved in the water of the central vacuole where they can reflect outside light and give the plant cell its color. Bright pigments such as anthocyanins are evolutionarily beneficial to plants because they attract potential pollinators and may play a role in protecting photosynthetic pigments from light induced stress (Glover & Martin, 2012).
- the color an anthocyanin molecule reflects is dependent on hydroxylation of two carbon rings in its molecular structure. For this reason, the pigment changes color in relation to the pH of its environment. When dissolved in an acidic solution containing a lower concentration of hydroxide ions, the pigments display colors ranging from orange to red. These colors are present in nature in a variety of plants, including raspberries and most other red fruits and vegetables. At a neutral pH, anthocyanins can appear violet or colorless, but as the pH increases, the color transitions to blue. Thus, the color or anthocyanin pigments has a direct relationship with the environment and follows a scale transitioning from red to blue as pH increases.
- Anthocyanidins are the basic structures of anthocyanins, with formula (I) where R 1 to R 7 are, independently, H, OH or OMe.
- anthocyanidins When anthocyanidins are found in their glycoside form (bonded to a sugar moiety) they are known as anthocyanins. There are reports of more than 500 different anthocyanins in nature. The main differences between them are the number of hydroxylated or methoxylated groups, the nature and number of sugars bonded to their structure, the aliphatic or aromatic carboxylates bonded to the sugar in the molecule and the position of these bonds. The substitution pattern of the six most common anthocyanidins and their abbreviations are shown in Table 1. The numbering of the substituents R n is as drawn in the formula (I) above.
- anthocyanin In order of relative abundance, the sugars found bound to anthocyanidins to form anthocyanins are glucose, rhamnose, galactose, xylose, arabinose and glucuronic acid.
- anthocyanin as used herein is intended to include both glycosylated anthocyanins and acylated anthocyanins.
- the main glycoside derivatives in nature are 3-monosides, 3-biosides, 3,5-diglucosides and 3,7-diglucosides.
- Acylated anthocyanins derivatives include one or more molecules of the acyl acids; p-coumaric, ferulic and caffeic; or the aliphatic acids; malonic and acetic; and may be esterified to the sugar molecule. Overall, the most widespread anthocyanin is cyanidin-3-O-glucoside.
- the anthocyanins of the present invention may have the formula (I) wherein R 1 , R 2 and R 4 are each independently H, OH, OMe, a sugar residue, or an acylated sugar residue; and R 3 , R 5 , R 6 and R 7 are each independently H, OH or OMe.
- the anthocyanins may be synthetic and/or natural anthocyanins.
- the at least one type of fruit or vegetable derived anthocyanin is obtained from a fruit or vegetable extract.
- obtained or “obtaining” is meant purifying, extracting, synthesizing, purchasing, or otherwise acquiring an anthocyanin dye composition naturally found in raspberries.
- an “extract” as used herein is a preparation made from any part or parts of a fruit or vegetable that comprises, generally in concentrated form, one or more anthocyanin compounds.
- the term “extract” is intended to include anthocyanin materials obtained from plant sources, such as leaves, roots, seeds, flowers, berries, fruit, for example, by routine isolation methods suitable from suitable plant sources. There are various methods for the extraction of anthocyanins known to those of skill in the art.
- the extract may be obtained from a fruit or vegetable selected from the group consisting of a red and purple cabbage, purple carrots, elderberry, hibiscus, purple potato, red and black currants, blueberries, cherries, purple grapes, and red and black raspberries.
- the extract is typically concentrated by various methods to provide a solution enriched in anthocyanins.
- ultrafiltration can be used to remove unwanted components by molecular weight cut offs.
- the retentate from the filtration can be stored as a liquid or, for example, can then be further concentrated into a powder by spray drying, freeze drying, flash drying, fluidized bed drying, ring drying, tray drying, vacuum drying, radio frequency drying or microwave drying.
- the extract should contain at least 10% by weight anthocyanin content.
- the extracts therefore, contain anthocyanin(s) and may also contain other plant materials such as other flavinoids, sugars, etc.
- the disclosure provides a pH sensitive dye comprising at least one type of raspberry ( Rupus sp.) anthocyanin (e.g., an anthocyanin extracted from a raspberry ( Rupus sp.)).
- Raspberries belong to the genus Rubus . Cultivated raspberries have been derived mainly from two species, the wild red raspberry ( Rubus ideaus ) and black raspberry ( Rubus occidentalis ). Purple type is a cross between the black and red raspberry, and yellow type is a mutant red raspberry. There are over 200 species of raspberries. Raspberries can be grown from the Arctic to the equator.
- Anthocyanins obtained from raspberries include, for example, an anthocyanin selected from the group consisting of cyanidin-3-sophoraside, cyanide-3-glucoside or pelargonidin-3-sophoroside.
- the anthocyanin is sensitive at least within a pH range of pH 6.0 to pH 8.0, a pH range of pH 5.0 to pH 9.0, a pH range of pH 4.0 to pH 10.0, a pH range of pH 2.0 to pH 13.0, or a pH range of pH 1.0 to pH 14.0.
- the pH sensitive dye composition is sensitive at least within a pH range of pH 5.0 to pH 10.0.
- the disclosure provides a pH sensitive dye composition comprising at least one type of anthocyanin derived from a fruit or vegetable.
- the anthocyanin can be derived from red and purple cabbage, purple carrots, red and black currants, blackberries, blueberries, cherries, purple grapes, or red and black raspberries.
- at least one type of anthocyanin is an anthocyanadin derivative selected from the group consisting of cyandin, delphinidin, peonidin, petunidin, pelargonidin and malvidin anthocyanadin derivatives.
- the at least one type of anthocyanin is obtained from a raspberry ( Rubus sp.) extract.
- the at least one type of anthocyanin is obtained from a red cabbage extract.
- anthocyanin undergoes is not permanent, but will continue to respond to different stimuli as the environment changes.
- anthocyanins have reversible properties that make them reusable. This property makes anthocyanin useful as a pH indicator of solutions and substances, including washable and reusable dressings.
- the pH sensitive dye composition changes color in response to changes in pH and provides an indicator of wound health.
- the pH sensitive dye composition is sensitive at least within a pH range of pH 6.0 to pH 8.0, a pH range of pH 5.0 to pH 9.0, a pH range of pH 4.0 to pH 10.0, a pH range of pH 4.0 to pH 12.0, a pH range of pH 2.0 to pH 13.0, or a pH range of pH 1.0 to pH 14.0.
- the pH sensitive dye composition is sensitive at least within a pH range of pH 5.0 to pH 10.0.
- the pH sensitive dye composition of the present invention may be used to color a variety of substrate materials.
- the pH sensitive dye composition is disposed within the substrate material of a wound dressing. More particularly, the pH sensitive dye composition is disposed within (e.g., impregnated within) said substrate material and trapped with the matrix of the substrate material.
- the pH sensitive dye is dispersed homogenously (i.e., uniformly dispersed) throughout the dressing.
- Conventional dressings include, for example, absorbent pads, absorbent cotton, gauze (e.g., gauze bandages and/or gauze pads), wrap (e.g., elastic wraps and/or gauze wraps), dermal patches, surgical drapes, bandage, tapes, cotton-tipped stick, adhesive bandages, or other support wrap or medical bandage or wound cover.
- dressing as used herein is also intended to cover casts (e.g., orthopedic cast, body cast, plaster cast, or surgical cast), frequently made from plaster, encasing a limb (or, in some cases, large portions of the body) to stabilize and hold anatomical structures, most often a broken bone (or bones), in place until healing is confirmed.
- the dressing is a sterile dressing.
- the dressing may be disposable, washable and/or reusable.
- the dressing is an adhesive bandage.
- An adhesive bandage is usually covered by a woven fabric, plastic, or latex strip which has an adhesive.
- Adhesive bandages usually have an absorbent pad, which is sometimes medicated with an antiseptic solution.
- Some bandages have a thin, porous-polymer coating over the pad to keep it from sticking to the wound. The bandage is applied such that the pad covers the wound, and the fabric or plastic sticks to the surrounding skin to hold the dressing in place and prevent dirt from entering the wound.
- Adhesive bandages may include, but are not limited to, strip bandages, winged bandages, fingertip bandages, butterfly bandages, knuckle bandages, triangular bandages, tube bandages, compression bandages, elastic bandages, gauze bandages, donut bandages, pressure bandages, sterile-strips, eye bandages, sterile burn sheets, and adhesive tape.
- the substrate material comprises an absorbent or water-permeable material.
- the absorbent or water-permeable material is capable of absorbing wound exudate.
- the dressing can be composed of a substrate material comprising woven materials, non-woven materials or both.
- the dressing comprises a fabric, cloth or sponge material.
- the dressing may be composed of natural and synthetic materials (e.g., natural or synthetic fibers).
- the substrate material may be composed of natural or synthetic fibers selected from the group consisting of rayon, polyester, polyurethane, polyolefin, cellulose, cellulose derivatives, cotton, orlon, nylon, hydrogel polymeric material, and combinations thereof.
- the substrate material can be an elastic substrate.
- Materials suitable for use as an elastic substrate in the present invention include materials which are elastic, conformable, porous, provide adequate compression and which are self-adhering. In general, the material is sufficiently porous if the material allows for the transmission of air and moisture vapor through the material.
- the pH sensitive dye compositions disclosed herein further comprise a “mordant” or “mordanting agent.”
- a mordant or “mordanting agent” are used interchangeably and refer to a substance capable of fixing and/or setting dyes on fabrics or tissue sections by forming a coordination complex with the dye, which then attaches to the fabric or tissue.
- a mordant may comprise metallic cations such as Al 3+ or Fe 3+ ions.
- the mordant includes tannic acid, alum, chrome alum, sodium chloride, and certain salts of aluminum, chromium, copper, iron, iodine, potassium, sodium, and tin.
- Exemplary mordants for use in the dye compositions disclosed herein include, for example aluminum potassium sulfate, copper sulfate, iron (III) oxide, copper sulfate, citric acid, iron (III) sulfate (Fe 2 (SO 4 ) 3 ) and sodium sulfate.
- the wound dressings disclosed herein further comprise at least one therapeutic agent.
- the wound dressings of the present invention may further comprise at least one therapeutic agent disposed within the substrate material.
- therapeutic agents include, but are not limited to, antibiotic agents (e.g., antimicrobial agents and/or antiseptic agents), anti-inflammatory agents, pain-relieving agents, wound closing adhesive agents, or antihistamine agents.
- the wound dressings of the present invention advantageously comprise at least one antibiotic agent.
- the wound dressings of the present invention may further comprise at least one antibiotic agent disposed within the substrate material.
- the antibiotic agent can be composed of any antibacterial compound that effectively prevents the growth of bacteria (e.g., bacteriostatic) or yeast (e.g. anti-yeast) and/or kills bacteria (e.g., bactericidal) or yeast once they are formed.
- the antimicrobial or antiseptic agents should preferably be safe, non-irritating, and hypoallergenic such that it does not cause any adverse reactions to the skin of the patient.
- Antibiotic agents that are suitable for use in the wound dressings include, for example, amikacin, amikacin sulfate, bacitracin, bacitracin zinc, chlortetracycline hydrochloride, dihydrostreptomycin sulfate, crystalline dihydrostreptomycin sulfate, dihydrostreptomycin hydrochloride, gentamicin sulfate, sterile gentamicin sulfate, kanamycin sulfate, sterile kanamycin sulfate, neomycin sulfate, sterile neomycin sulfate, netilmicin sulfate, oxytetracycline, paromomycin sulfate, polymyxin B, polymyxin B sulfate, sisomicin sulfate, sterile streptomycin sulfate, tetracycline hydrochloride, tobramycin and
- body tissues for example wounds to human or animal bodies
- characteristics of the wound for example the pH of exudates.
- To facilitate detailed assessment of a wound correct diagnosis and hence selection of an appropriate treatment is needed.
- the disclosure provides methods for determining the status of a wound by assessing the pH of a wound and/or wound exudate. Such wound pH information may be used to facilitate selection of the appropriate treatment to which the wound should be subjected.
- the methods for determining the status of a wound disclosed herein comprise applying a dressing on a wound surface, wherein the dressing comprises a substrate material, and a pH sensitive dye composition disposed within the substrate material comprising at least one type of fruit or vegetable derived anthocyanin; and determining the status of the wound by assessing the color change of the pH sensitive dye after application of the dressing onto the wound surface.
- the color change of the pH sensitive dye provides information about the pH of the wound, and thus provides information as to the status (e.g., health) of the wound.
- the pH of the wound is assessed on the basis of a change in the visual appearance of said substrate material. More specifically, the pH of the wound is assessed on the basis of the color of said substrate material.
- Assessing the color change of the pH sensitive dye composition comprises monitoring the color change of the dressing over time. Appropriate timing for monitoring the color change of the wound dressing may be determined by a healthcare professional or caregiver attending to the subject. For example, assessing the color change of the color of the pH sensitive dye composition may be performed by monitoring the color change of the dressing for a period between 1 to 24 hours, a period of between 2 to 16 hours, a period of between 3 to 12 hours, a period of between 4 to 10 hours, or a period of between 6 to 8 hours after application of the dressing onto the wound surface.
- assessing the color change of the pH sensitive dye composition comprises monitoring the color change of the dressing at predetermined time intervals after application of the dressing onto the wound surface, i.e., at fifteen minute, thirty minute, one hour, two hour, four hour, six hour, eight hour, twelve hour or twenty hour time intervals after application of the dressing onto the wound surface.
- the color change of the pH sensitive dye can be monitored by visual inspection (e.g., visual inspection by the human eye) or with the aid of a color-sensing device.
- Color sensing devices include, for example, a colorimeter or spectrophotometer. Colorimeters and spectrophotometers are well-known in the art and are used to measure certain optical properties of various materials.
- the color change of the pH sensitive dye can be monitored using an imaging device, such a digital camera, a mobile phone, a smartphone, a tablet, a portable computer, a computer, and a scanner.
- the method comprises assessing the color change of the pH sensitive dye after application of the dressing onto the wound surface; and, subsequently, carrying out another step in dependence upon the pH assessed.
- the additional step can be advising a healthcare professional or caregiver to provide or select a treatment regimen for said wound, or advising a caregiver to remove/change/replace the wound dressing from the wound surface when the color of the wound dressing indicates a basic pH.
- the pH sensitive composition may serve as an indicator of bacterial growth in the wound through the change in color thereof (the pH will stay basic). Following evidence of bacterial growth in the wound, the wound can be cleaned, disinfected, and dressed with a sterile dressing immediately after a wearer is aware of it.
- the method may involve comparing the visual appearance, for example color, of the dressing with a reference means, for example a color reference means such as a color chart (or the like) to assess the pH of the dressing or environment.
- a reference means for example a color reference means such as a color chart (or the like) to assess the pH of the dressing or environment.
- the dressing material may be arranged to enable pH information to be obtained directly from it without recourse to any external reference means.
- said test material may incorporate a said reference means suitably arranged to enable pH information to be obtained directly from the test material.
- the methods disclosed herein can include the step of recording information relating to the visual appearance (e.g., the color) of the substrate material.
- the color of the dressing may be recorded and/or the pH may be recorded.
- the methods further comprise modifying the subject's clinical record to include information relating to the visual appearance (e.g., the color) of the wound dressing and the status of the wound.
- the clinical record may be stored in any suitable data storage medium (e.g., a computer readable medium).
- a dye was made from raspberry juice and aluminum potassium sulfate. Cotton bandages were dyed and exposed to different pH levels as well as bacterial growth. Photographs were taken before and after the bandages were placed in different environments. The environments tested were pH values 5-9. Also, one group was exposed to bacterial growth on decomposing chicken. Red, green and blue values were extracted from the images using Adobe Photoshop Elements 11, and averaged to find before and after colors of each piece of cotton. The resulting color values were used to analyze the changes in color between each pH.
- Acidic pH solutions turned the raspberry puree redder, and a neutral environment changes the puree to a purplish color.
- Basic environments resulted in a drastic transformation to a blue-green color.
- the apparent color changes provided evidence that the main pigment (anthocyanin) is halochromic, which enabled the next test to be conducted.
- Raspberry juice does not fix naturally into cotton textiles, so two mordants were tested for their usefulness in attaching the juice to the fabric. Iron (III) oxide and aluminum potassium sulfate were selected as mordants. Each mordant was added to a solution consisting of equal parts water and raspberry puree and to a solution containing raspberry puree, water, and magnesium hydroxide (CVS Brand unflavored Milk of Magnesia).
- Pieces of fabric were placed in each of the four prepared solutions, and the solutions were heated to 65° C.
- the aluminum mordant without the added magnesium worked best, producing a bright red color like that of raspberry fruit.
- FIG. 2 The iron mordant without aluminum produced a duller, lighter red.
- Both pieces of fabric that were exposed to magnesium in solution did not dye evenly and resulted in spotted, uneven coloring.
- When exposed to different pH values only the fabric dyed in an aluminum potassium sulfate solution without magnesium was capable of color change. This dye was selected as the optimum for dyeing fabric in future experiments.
- Varying pH was shown to affect the dye, so an experiment was designed to test the color changes of the fabric in conditions mimicking the environment produced by a skin wound.
- Unflavored gelatin Knox Brand
- Knox Brand was set in petri dishes to replicate the surface of human skin, and holes were poked into the gelatin with a sewing needle to imitate pores that would leak bodily fluid.
- Each sample was then brushed with a solution of a different pH, varying from 5 to 9. The mixtures were allowed to briefly soak into each of the artificial pores, but some solution still remained on the surface of the gelatin.
- the pH solutions were produced with household items: lemon and lime juice were used to acidify pH values, water was used to neutralize pH values, and baking soda was used to alkalize pH values.
- a piece of sterilized gauze was then laid on the top of the gelatin in each petri dish.
- Four gauze samples were tested in each pH: two samples that had been previously soaked in acetic acid and two samples that had been previously rinsed in water. Before the samples were tested, they were sterilized in an ethylene oxide machine. The newly sterilized bandage squares were left on petri dishes of varying pH values for approximately 15 minutes to fully absorb the solution. After the allotted time, each piece was placed onto a white sheet of paper and photographed with a camera (Nikon D3100).
- Bacterial growth conditions were tested to determine if the dyed fabric could be used to signal bacterial infection by changing color when in contact with infected areas.
- 4 pieces of raw chicken Purdue chicken breasts
- solutions with pH 5 through pH 9.
- strips of medical gauze dyed with the aluminum potassium sulfate dye were placed on pieces of chicken.
- the samples were each sealed in individual bags (Ziploc sandwich bags) and left in a residential garage for three days. The chicken was purposefully left to decompose to see what color changes the gauze would undergo in the presence of bacterial growth.
- the dyed fabric was exposed to S. aureus in petri dishes.
- the cultures were obtained from a laboratory at Becker College and remained in the laboratory and sealed for the duration of the observation.
- the bandages were dyed and rinsed in water to remove excess dye, resulting in a purple color. They were also autoclaved to before being exposed to the cultures to prevent outside contamination.
- the purple bandages were laid on top of S. aureus in petri dishes and observed after a two-day growth period. Photographs of the bandages were taken at this time to access color change.
- the bacterial colonies were autoclaved and discarded by a professional biohazard disposal company.
- the data shows a clear relationship between pH and color.
- FIG. 4 shows the blue RGB values obtained were plotted against the red RGB values before and after pH soaking.
- Each line represents a pH, connecting the initial Red-Blue point, noted in black, to the final Red-Blue point.
- green is the lowest value and is not predominantly seen in the images.
- the blue value is the highest, followed by red, which combine to make the bluish purple seen in the fabric.
- the dyed fabric was rinsed with acetic acid before being exposed to varying pH values.
- two pieces of dyed, sterilized cotton bandage were rinsed in acetic acid and then soaked in each pH 5 to 9 on top of gelatin to simulate skin conditions. Photos were taken before the pH was changed and afterward, and RGB values were obtained from these images and are recorded in the chart above.
- the acetic acid rinse was done to simulate the application of acetic acid to a wound, which is done to lower pH and promote healing.
- the dyed gauze also showed a response to pH changes due to bacterial contamination.
- the fabric was also exposed to a specific type of bacteria, Staphylococcus Aureus .
- the fabric was sterilized in an autoclave before exposure to the bacteria to ensure no outside contamination would occur.
- the fabric began at a purple color after being rinsed in water, shown in Table 4.
- the color change in the presence of this type of bacteria is consistent regardless of starting color, as shown by the starting color variations leading to the same final color.
- the fabric responded as was predicted because bacteria often create high pH environments, which would result in a bluish grey color similar to the final color of previous experiments.
- the dyed cotton gauze responded to changes in environmental pH in each test performed.
- the fabric could also be used on patients with burns in order to learn more about the health of their wounds without removing the bandage, which is often a very painful process.
- the dyed gauze was sterilized successfully in both an autoclave and an ethylene oxide machine, showing it could be sterilized with existing equipment.
- the dyed cotton fabric used in this experiment could be made into smaller products for home use. This could help the layperson identify infection in small wounds and cuts. Overall, the cotton bandages in this experiment would be helpful in monitoring the state of any injury leaking bodily fluid.
Abstract
Description
- This application is a divisional application of U.S. patent application Ser. No. 15/830,188, filed on Dec. 4, 2017, which is a divisional application of U.S. patent application Ser. No. 14/514,579, filed on Oct. 15, 2014, now U.S. Pat. No. 9,855,364, the entire contents of which are hereby incorporated by reference.
- The invention generally relates to wound dressings and their methods of use. More particularly, the invention relates to wound dressings dyed with a pH sensitive dye composition comprising at least one anthocyanin obtained from (e.g., derived from) a fruit or vegetable extract, and methods of using the wound dressings for monitoring wound health.
- The pH of a wound often signifies important information about wound health. Measuring the pH of a wound can provide information about the stage of healing and the presence of infection. The pH of wound leakage has been shown to change as the wound heals and if the wound becomes infected. The natural pH of skin is slightly acidic, ranging from 4.8 to 6.0, an adaptation which wards off bacteria on the surface, but the interstitial fluid in the body has a pH closer to neutral (Romanelli, M, et al., 2002). In healing wounds, pH starts slightly basic, moves to neutral, and then approaches the pH of normal skin (Gethin, G 2007). Healthy wounds usually follow this trend, and it can be problematic if a wound does not. If healing is not progressing, the pH will stay basic. Wounds that remain basic usually heal more slowly because the tissue does not have enough access to oxygen. Small pH changes within a wound can cause large changes in oxygen availability (Leveen, H. et al., 1973). The more oxygen available in a wound, the faster a wound will heal. This makes pH fluctuations critical to wound health and the healing process.
- Infection inhibits wound healing by raising wound pH. Many bacteria produce ammonia, which has a pH of 11.6 in a 1.0 M aqueous solution. Ammonia production raises the pH of a wound and lowers the oxygen availability. With a decreased oxygen supply, a wound will take much longer to heal (Leveen, H. et al., 1973). The bacteria present in an infection negatively affect the wound and its oxygen content. Bacteria and other factors can result in long periods of time in which the wound environment is at a basic pH. Because this can slow healing, measures are often taken to lower wound pH. Thus, measuring the pH of a wound can provide information about the stage of healing and the presence of infection.
- Thus, there is a need for improved bandages capable of detecting pH to provide noninvasive, immediate information about a wound to help individualize treatment.
- At least in part, the present invention relates to a wound dressing, such as gauze, bandages, and surgical tapes, impregnated with a pH sensitive dye composition comprising an anthocyanin dye.
- In some aspects, this disclosure provides a wound dressing. In some embodiments, the wound dressing comprising a substrate material and a pH sensitive dye composition disposed within the substrate material and comprising at least one fruit or vegetable derived anthocyanin.
- As used herein, the terms “dressing” and “wound dressing” are used interchangeably and refer to a material applied to a wound to promote healing and/or prevent further harm.
- As used herein, the term “wound” refers to an injury to living tissue caused by a cut, blow, laceration, surgical incision or other impact, typically one in which the skin is cut or broken. Types of injures include, for example, cuts, scrapes, scratches, burns, blisters, insect bites, and surgical sites, to name a few.
- In other aspects, this disclosure provides methods for manufacturing a wound dressing, comprising: providing a substrate material; and disposing pH sensitive dye composition comprising at least one fruit or vegetable derived anthocyanin within the substrate material.
- Thus, the invention provides wound dressing and methods of use thereof, which utilize a pH sensitive dye composition comprising at least one fruit or vegetable derived anthocyanin. For example, a pH sensitive dye composition comprising at least one anthocyanin is derived from a fruit or vegetable selected from the group consisting of a red cabbage, purple cabbage, purple carrots, elderberry, hibiscus, purple potato, red currant, black currants, blueberries, cherries, purple grapes, red raspberries and black raspberries. In another exemplary embodiment, wound dressing and methods of use thereof that use a pH sensitive dye composition utilize a pH sensitive dye composition comprising at least one anthocyanin is derived from red cabbage. In another exemplary embodiment, wound dressing and methods of use thereof that use a pH sensitive dye composition utilize a pH sensitive dye composition comprising at least one anthocyanin is derived from a raspberry (Rubus sp.). In some embodiments, at least one anthocyanin is selected from the group consisting of cyaniding-3-sophoraside, cyanide-3-glucoside or pelargonidin-3-sophoroside.
- Additionally, the “Anthocyanins” as used herein include anthocyanadin derivatives selected from the group consisting of cyandin, delphinidin, peonidin, petunidin, pelargonidin and malvidin anthocyanadin derivatives.
- In some embodiments, the pH sensitive dye composition is sensitive at least within a pH range of pH 4.0 to pH 12.0, inclusive.
- In some embodiments, the pH sensitive dye composition comprises a mordant, which are well known to the skilled artisan. For example, the pH sensitive dye composition may comprise a mordant selected from the group consisting of aluminum potassium sulfate, copper sulfate, iron (III) oxide, copper sulfate, citric acid, iron (III) sulfate (Fe2(SO4)3) and sodium sulfate. In an exemplary embodiment, the mordant is aluminum potassium sulfate.
- The wound dressing may be any dressing suitable for application to the surface of a wound, including, for example an open wound. In some embodiments, the wound dressing is selected from the group consisting of a pad, wrap, bandage, tape, cotton-tipped stick and adhesive strip bandage.
- In some embodiments, the substrate material comprises an absorbent or water-permeable material. The absorbent or water-permeable material is capable of absorbing wound exudate. Suitable absorbent materials will preferably absorb at least about 10% by weight, at least about 20% by weight, at least about 30% by weight, at least about 50% by weight, at least about 75% by weight, or at least about 100% by weight of fluid or exudate. The dressing can be composed of a substrate material comprising woven materials, non-woven materials or both. In some embodiments, the dressing comprises a fabric, cloth or sponge material. The dressing may be composed of natural and synthetic materials. In an exemplary embodiment, the substrate material comprises cotton material including, cotton fabric or cotton gauze.
- In some embodiments, the wound dressing further comprises at least one therapeutic agent selected from the group consisting of antimicrobial agents, antiseptic agents, anti-inflammatory agents, pain relieving agents, wound closing adhesive agents, and antihistamine agents.
- The pH sensitive dye composition provides a clear and obvious indication of wound health. For example, the pH sensitive dye composition can provide an indication as to whether an antimicrobial therapy is effective for treating or preventing wound infection.
- In some aspects, this disclosure provides methods for determining the status of a wound, the methods comprising applying a wound dressing on a wound surface, wherein the wound dressing comprises a substrate material, and a pH sensitive dye composition disposed within the substrate material and comprising at least one fruit or vegetable derived anthocyanin; and determining the status of the wound by assessing the color change of the pH sensitive dye composition after application of the dressing onto the wound surface.
- In some other aspects, this disclosure provides methods treating a wound comprising: applying a wound dressing to the surface of the wound, wherein the wound dressing comprises a substrate material; and a pH sensitive dye composition disposed within the substrate material and comprising at least one fruit or vegetable derived anthocyanin; assessing the color of the wound dressing after application of the dressing onto the wound surface; and selecting a treatment plan based on the status of the wound based on the color of the wound dressing application to the wound surface.
- In some embodiments, assessing the color change of the pH sensitive dye composition comprises monitoring the color change of the dressing over time. Assessing the color change of the pH sensitive dye composition may comprise monitoring the color change of the dressing for a period between 1 to 24 hours, a period of between 2 to 16 hours, a period of between 3 to 12 hours, a period of between 4 to 10 hours, or a period of between 6 to 8 hours after application of the dressing onto the wound surface. Assessing the color change of the pH sensitive dye composition may comprise monitoring the color change of the wound dressing at predetermined time intervals, such as, for example, one hour, two hour, four hour, six hour, eight hour, twelve hour or twenty-four hour time intervals following application of the dressing onto the wound surface.
- The color change of the pH sensitive dye composition may be accomplished using the human eye or with the assistance of a visualization aide. For instance, assessing the color change of the pH sensitive dye composition can be performed by visual inspection or by using a color-sensing device. In some embodiments, the color-sensing device is selected from the group consisting of a colorimeter and a spectrometer.
- Assessing the color change of the pH sensitive dye composition can be performed using an imaging device. In some embodiments, the imaging device is selected from the group consisting of a colorimeter, spectrometer, a digital camera, a mobile phone, a smartphone, a tablet, a portable computer, a computer, and a scanner.
- In some embodiments, the methods provided herein further comprising removing or replacing the wound dressing when the color of the wound dressing indicates a basic pH.
- In some aspects, the methods for treating a wound provided herein comprise selecting a treatment plan based on the status of the wound. The treatment plan can comprise removing or replacing the wound dressing when the color or the wound dressing indicates a basic pH. In some embodiments, the treatment plan comprises selectively administering one or more therapeutic agents and at least one therapeutic agent selected from the group consisting of antimicrobial agents, antiseptic agents, anti-inflammatory agents, pain relieving agents, wound closing adhesive agents, and antihistamine agents to the wound.
- As used herein, the term “one or more” includes at least one, more suitably, one, two, three, four, five, ten, twenty, fifty, one-hundred, five-hundred, etc., of the item to which “one or more” refers. The term “at least one” as used in the present invention stands for one, two, three, four, five, ten, twenty, fifty, one-hundred, five-hundred, etc., or more of the item “at least one” refers to.
- Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Methods and materials are described herein for use in the present invention; other, suitable methods and materials known in the art can also be used. The materials, methods, and examples are illustrative only and not intended to be limiting. All publications, patent applications, patents, sequences, database entries, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control.
- Other features and advantages of the invention will be apparent from the following detailed description and figures, and from the claims.
- The patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
-
FIG. 1 is a photograph demonstrating the gradient of colors for raspberry puree at pH 4.0, pH 5.0, pH 6.0, pH 7.0, pH 8.0, and pH 9.0 (top row, left to right: pH 4.0, pH 5.0, pH 6.0; bottom row, left to right: pH 7.0, pH 8.0, pH 9.0). -
FIG. 2 is a photograph showing the bright red color of sample gauze and other medical bandages dyed with raspberry juice in an aluminum potassium sulfate solution without magnesium. -
FIG. 3 are photographs demonstrating the color of dyed fabric before (left hand images) and after (right hand images) pH exposure (pH 5.0 (top row), pH 6.0 (middle row) and pH 7.0 (bottom row)). -
FIG. 4 is a graph demonstrating blue RGB values plotted against red RGB values before and after soaking. Each line represents a pH, connecting the initial Red-Blue point, noted in black, to the final Red-Blue point. -
FIG. 5 is a graph demonstrating blue RGB values plotted against red RGB values before and after pH soaking. Each line represents a pH, connecting the initial Red-Blue point, noted in black, to the final Red-Blue point. -
FIG. 6 is a graph demonstrating blue RGB values plotted against red RGB values before and after bacterial exposure. Each line represents a pH, connecting the initial Red-Blue point to the final Red-Blue point, noted in black. - The present invention is based, in part, on the discovery that wound dressing materials impregnated with a pH-sensitive dye composition comprising at least one anthocyanin derived from a fruit or vegetable source, including for example an anthocyanin derived from raspberries (Rubus sp.), can be used on patients with long-term or chronic wounds to detect wound health and infection. Thus, in one aspect, the disclosure provides wound dressings designed for application to a wound, the wound dressing comprising a substrate material, and a pH sensitive dye composition disposed within the substrate material and comprising at least one anthocyanin dye derived from a fruit or vegetable. Advantageously, the wound dressings described herein absorb wound exudate and provide an indication of wound pH, and thus indication of wound health. The dressings provided herein provide noninvasive, immediate information about a wound to help individualize treatment.
- In one aspect, the disclosure further provides methods for determining the pH of a wound, comprising contacting the wound with a dressing containing at least one anthocyanin dye derived from a fruit or vegetable; and monitoring the color change of the dressing material to determine the pH of the wound.
- Wound dressings are often integral to wound healing. Wound dressings are prepared in many forms and for many different uses. Generally, a dressing is designed to be in direct contact with the wound and may be used in the form of a wrap or bandage. Aside from the major function of reducing the risk of infection, wound dressings are also important for providing a protective barrier from outside sources of irritation and provide mechanical support to the fragile wound surface. Wound dressings also function to absorb wound byproducts (e.g. excess blood, plasma, or other fluids) that tend to accumulate and complicate healing. Would dressings serve to form an occlusive barrier to provide an optimal environment for certain wound types, and act as an agent for wound debridement, which acts to clean and prepare a wound bed for healing.
- The pH of a wound may be assessed using a wound dressing as disclosed herein, which changes color in dependence upon pH. Such wound pH information may be used to facilitate selection of the appropriate treatment to which the wound should be subjected. The wound dressing can be sterilized in an autoclave and loaded with antibacterial/antiseptic agents to provide a wound dressing which will indicate the pH of wound exudates in a non-invasive and simple manner.
- In practice, a wound dressing as disclosed herein would be applied to a wound site of a subject with a surface of the wound dressing in contact with a surface of the wound. The wound dressing then would be monitored over a predetermined time period to assess the extent of the exudate present in the dressing.
- In chemistry, chromism is a process that induces a reversible change in the colors of compounds. In most cases, chromism is based on a change in the electron states of molecules, so this phenomenon is induced by various external stimuli which can alter the electron density of substances. It is known that there are many natural compounds that have chromism, and many artificial compounds with specific chromism have been synthesized to date. Chromism is classified by what kinds of stimuli are used.
- Color change can occur by changes in electromagnetic radiation, reflection, absorption or scattering. Thus, for example, photochromism signifies color change triggered by electromagnetic radiation; thermochromism signifies color change triggered by changes in temperature; electrochromism signifies changes in color occurring due to gain or loss of electrons; solvatochromism signifies color change resulting from changes in solvent polarity; ionochromism signifies color change caused by ions; tribochromism caused by changes in mechanical friction; piezochromism signifies changes caused by mechanical pressure; and halochromism signifies color change caused by a change in pH. Although fundamentally the halochromism is pH-dependent, the temperature-dependence of the acid-base equilibrium means that pH sensitivity can result in thermochromic behavior.
- Anthocyanins are a class of halochromatic substances which respond to the level of acidity in an environment with a color change (Van der Schueren, L. & De Clerck, K., 2012). Anthocyanins pigments are responsible for the red, purple, and blue colors of many fruits and vegetables, including red and purple cabbage, beets, purple carrots, elderberry, hibiscus, purple potato, red and black currants, blueberries, cherries, purple grapes, and red and black raspberries. Within the plant they serve as key antioxidants and pigments contributing to the coloration of flowers. Anthocyanin pigment has a color gradient from orange to blue in the visible light spectrum, following the range of possible pH values. In the ultraviolet spectrum, the colors range from browns and yellows to purples and blues.
- The color the anthocyanin molecule displays can change in relation to its environment; it is behind the color transition of green to red leaves from summer to autumn. These pigments are formed inside the plant through a metabolic pathway utilizing phenylalanine. Inside a plant cell, anthocyanins are dissolved in the water of the central vacuole where they can reflect outside light and give the plant cell its color. Bright pigments such as anthocyanins are evolutionarily beneficial to plants because they attract potential pollinators and may play a role in protecting photosynthetic pigments from light induced stress (Glover & Martin, 2012).
- The color an anthocyanin molecule reflects is dependent on hydroxylation of two carbon rings in its molecular structure. For this reason, the pigment changes color in relation to the pH of its environment. When dissolved in an acidic solution containing a lower concentration of hydroxide ions, the pigments display colors ranging from orange to red. These colors are present in nature in a variety of plants, including raspberries and most other red fruits and vegetables. At a neutral pH, anthocyanins can appear violet or colorless, but as the pH increases, the color transitions to blue. Thus, the color or anthocyanin pigments has a direct relationship with the environment and follows a scale transitioning from red to blue as pH increases.
- Anthocyanidins are the basic structures of anthocyanins, with formula (I) where R1 to R7 are, independently, H, OH or OMe.
- When anthocyanidins are found in their glycoside form (bonded to a sugar moiety) they are known as anthocyanins. There are reports of more than 500 different anthocyanins in nature. The main differences between them are the number of hydroxylated or methoxylated groups, the nature and number of sugars bonded to their structure, the aliphatic or aromatic carboxylates bonded to the sugar in the molecule and the position of these bonds. The substitution pattern of the six most common anthocyanidins and their abbreviations are shown in Table 1. The numbering of the substituents Rn is as drawn in the formula (I) above.
-
TABLE 1 Common anthocyanidins Name (Abbreviation) R1 R2 R3 R4 R5 R6 R7 Cyanidin (CN) OH OH H OH OH OH H Delphinidin (Pp) OH OH H OH OH OH OH Pelagonidin (Pg) OH OH H OH H OH H Peonidin (Pn) OH OH H OH OMe OH H Petunidin (Pt) OH OH H OH OMe OH OH Malvidin (Mv) OH OH H OH OmE OH OME - In order of relative abundance, the sugars found bound to anthocyanidins to form anthocyanins are glucose, rhamnose, galactose, xylose, arabinose and glucuronic acid. The term “anthocyanin” as used herein is intended to include both glycosylated anthocyanins and acylated anthocyanins. The main glycoside derivatives in nature are 3-monosides, 3-biosides, 3,5-diglucosides and 3,7-diglucosides. Acylated anthocyanins derivatives include one or more molecules of the acyl acids; p-coumaric, ferulic and caffeic; or the aliphatic acids; malonic and acetic; and may be esterified to the sugar molecule. Overall, the most widespread anthocyanin is cyanidin-3-O-glucoside. The anthocyanins of the present invention may have the formula (I) wherein R1, R2 and R4 are each independently H, OH, OMe, a sugar residue, or an acylated sugar residue; and R3, R5, R6 and R7 are each independently H, OH or OMe. The anthocyanins may be synthetic and/or natural anthocyanins.
- In some embodiments, the at least one type of fruit or vegetable derived anthocyanin is obtained from a fruit or vegetable extract. By “obtained” or “obtaining” is meant purifying, extracting, synthesizing, purchasing, or otherwise acquiring an anthocyanin dye composition naturally found in raspberries.
- An “extract” as used herein is a preparation made from any part or parts of a fruit or vegetable that comprises, generally in concentrated form, one or more anthocyanin compounds. The term “extract” is intended to include anthocyanin materials obtained from plant sources, such as leaves, roots, seeds, flowers, berries, fruit, for example, by routine isolation methods suitable from suitable plant sources. There are various methods for the extraction of anthocyanins known to those of skill in the art. The extract may be obtained from a fruit or vegetable selected from the group consisting of a red and purple cabbage, purple carrots, elderberry, hibiscus, purple potato, red and black currants, blueberries, cherries, purple grapes, and red and black raspberries.
- The extract is typically concentrated by various methods to provide a solution enriched in anthocyanins. For example, ultrafiltration can be used to remove unwanted components by molecular weight cut offs. The retentate from the filtration can be stored as a liquid or, for example, can then be further concentrated into a powder by spray drying, freeze drying, flash drying, fluidized bed drying, ring drying, tray drying, vacuum drying, radio frequency drying or microwave drying. Ultimately, the extract should contain at least 10% by weight anthocyanin content. The extracts, therefore, contain anthocyanin(s) and may also contain other plant materials such as other flavinoids, sugars, etc.
- In one embodiment, the disclosure provides a pH sensitive dye comprising at least one type of raspberry (Rupus sp.) anthocyanin (e.g., an anthocyanin extracted from a raspberry (Rupus sp.)). Raspberries belong to the genus Rubus. Cultivated raspberries have been derived mainly from two species, the wild red raspberry (Rubus ideaus) and black raspberry (Rubus occidentalis). Purple type is a cross between the black and red raspberry, and yellow type is a mutant red raspberry. There are over 200 species of raspberries. Raspberries can be grown from the Arctic to the equator. Anthocyanins obtained from raspberries (Rubus sp.) include, for example, an anthocyanin selected from the group consisting of cyanidin-3-sophoraside, cyanide-3-glucoside or pelargonidin-3-sophoroside.
- In some embodiments, the anthocyanin is sensitive at least within a pH range of pH 6.0 to pH 8.0, a pH range of pH 5.0 to pH 9.0, a pH range of pH 4.0 to pH 10.0, a pH range of pH 2.0 to pH 13.0, or a pH range of pH 1.0 to pH 14.0. In one embodiment, the pH sensitive dye composition is sensitive at least within a pH range of pH 5.0 to pH 10.0.
- In some aspects, the disclosure provides a pH sensitive dye composition comprising at least one type of anthocyanin derived from a fruit or vegetable. For example, the anthocyanin can be derived from red and purple cabbage, purple carrots, red and black currants, blackberries, blueberries, cherries, purple grapes, or red and black raspberries. In some embodiments, at least one type of anthocyanin is an anthocyanadin derivative selected from the group consisting of cyandin, delphinidin, peonidin, petunidin, pelargonidin and malvidin anthocyanadin derivatives. In some embodiments, the at least one type of anthocyanin is obtained from a raspberry (Rubus sp.) extract. In yet another embodiment, the at least one type of anthocyanin is obtained from a red cabbage extract.
- The color change anthocyanin undergoes is not permanent, but will continue to respond to different stimuli as the environment changes. Thus, anthocyanins have reversible properties that make them reusable. This property makes anthocyanin useful as a pH indicator of solutions and substances, including washable and reusable dressings.
- The pH sensitive dye composition changes color in response to changes in pH and provides an indicator of wound health. In some embodiments the pH sensitive dye composition is sensitive at least within a pH range of pH 6.0 to pH 8.0, a pH range of pH 5.0 to pH 9.0, a pH range of pH 4.0 to pH 10.0, a pH range of pH 4.0 to pH 12.0, a pH range of pH 2.0 to pH 13.0, or a pH range of pH 1.0 to pH 14.0. In one embodiment, the pH sensitive dye composition is sensitive at least within a pH range of pH 5.0 to pH 10.0.
- The pH sensitive dye composition of the present invention may be used to color a variety of substrate materials. According to an aspect of the present invention, the pH sensitive dye composition is disposed within the substrate material of a wound dressing. More particularly, the pH sensitive dye composition is disposed within (e.g., impregnated within) said substrate material and trapped with the matrix of the substrate material. In some embodiments, the pH sensitive dye is dispersed homogenously (i.e., uniformly dispersed) throughout the dressing.
- Conventional dressings include, for example, absorbent pads, absorbent cotton, gauze (e.g., gauze bandages and/or gauze pads), wrap (e.g., elastic wraps and/or gauze wraps), dermal patches, surgical drapes, bandage, tapes, cotton-tipped stick, adhesive bandages, or other support wrap or medical bandage or wound cover. The term “dressing” as used herein is also intended to cover casts (e.g., orthopedic cast, body cast, plaster cast, or surgical cast), frequently made from plaster, encasing a limb (or, in some cases, large portions of the body) to stabilize and hold anatomical structures, most often a broken bone (or bones), in place until healing is confirmed. In some embodiments, the dressing is a sterile dressing. The dressing may be disposable, washable and/or reusable.
- In some embodiments, the dressing is an adhesive bandage. An adhesive bandage is usually covered by a woven fabric, plastic, or latex strip which has an adhesive. Adhesive bandages usually have an absorbent pad, which is sometimes medicated with an antiseptic solution. Some bandages have a thin, porous-polymer coating over the pad to keep it from sticking to the wound. The bandage is applied such that the pad covers the wound, and the fabric or plastic sticks to the surrounding skin to hold the dressing in place and prevent dirt from entering the wound. Adhesive bandages may include, but are not limited to, strip bandages, winged bandages, fingertip bandages, butterfly bandages, knuckle bandages, triangular bandages, tube bandages, compression bandages, elastic bandages, gauze bandages, donut bandages, pressure bandages, sterile-strips, eye bandages, sterile burn sheets, and adhesive tape.
- In some embodiments, the substrate material comprises an absorbent or water-permeable material. The absorbent or water-permeable material is capable of absorbing wound exudate. The dressing can be composed of a substrate material comprising woven materials, non-woven materials or both. In some embodiments, the dressing comprises a fabric, cloth or sponge material. The dressing may be composed of natural and synthetic materials (e.g., natural or synthetic fibers). For example, the substrate material may be composed of natural or synthetic fibers selected from the group consisting of rayon, polyester, polyurethane, polyolefin, cellulose, cellulose derivatives, cotton, orlon, nylon, hydrogel polymeric material, and combinations thereof.
- In use, the substrate material can be an elastic substrate. Materials suitable for use as an elastic substrate in the present invention include materials which are elastic, conformable, porous, provide adequate compression and which are self-adhering. In general, the material is sufficiently porous if the material allows for the transmission of air and moisture vapor through the material.
- In some aspects, the pH sensitive dye compositions disclosed herein further comprise a “mordant” or “mordanting agent.” As used herein, the term “mordant” and “mordanting agent” are used interchangeably and refer to a substance capable of fixing and/or setting dyes on fabrics or tissue sections by forming a coordination complex with the dye, which then attaches to the fabric or tissue. A mordant may comprise metallic cations such as Al3+ or Fe3+ ions. In some embodiments, the mordant includes tannic acid, alum, chrome alum, sodium chloride, and certain salts of aluminum, chromium, copper, iron, iodine, potassium, sodium, and tin. Exemplary mordants for use in the dye compositions disclosed herein include, for example aluminum potassium sulfate, copper sulfate, iron (III) oxide, copper sulfate, citric acid, iron (III) sulfate (Fe2(SO4)3) and sodium sulfate.
- In some aspects, the wound dressings disclosed herein further comprise at least one therapeutic agent. For example, in addition to the pH sensitive dye compositions, the wound dressings of the present invention may further comprise at least one therapeutic agent disposed within the substrate material. Examples of therapeutic agents include, but are not limited to, antibiotic agents (e.g., antimicrobial agents and/or antiseptic agents), anti-inflammatory agents, pain-relieving agents, wound closing adhesive agents, or antihistamine agents.
- In one embodiment, the wound dressings of the present invention advantageously comprise at least one antibiotic agent. For example, the wound dressings of the present invention may further comprise at least one antibiotic agent disposed within the substrate material. The antibiotic agent can be composed of any antibacterial compound that effectively prevents the growth of bacteria (e.g., bacteriostatic) or yeast (e.g. anti-yeast) and/or kills bacteria (e.g., bactericidal) or yeast once they are formed. The antimicrobial or antiseptic agents should preferably be safe, non-irritating, and hypoallergenic such that it does not cause any adverse reactions to the skin of the patient. Antibiotic agents that are suitable for use in the wound dressings include, for example, amikacin, amikacin sulfate, bacitracin, bacitracin zinc, chlortetracycline hydrochloride, dihydrostreptomycin sulfate, crystalline dihydrostreptomycin sulfate, dihydrostreptomycin hydrochloride, gentamicin sulfate, sterile gentamicin sulfate, kanamycin sulfate, sterile kanamycin sulfate, neomycin sulfate, sterile neomycin sulfate, netilmicin sulfate, oxytetracycline, paromomycin sulfate, polymyxin B, polymyxin B sulfate, sisomicin sulfate, sterile streptomycin sulfate, tetracycline hydrochloride, tobramycin and sterile tobramycin sulfate.
- Methods for Assessing Wound Health
- The treatment of body tissues, for example wounds to human or animal bodies can be problematic due to difficulties in assessing characteristics of the wound, for example the pH of exudates. To facilitate detailed assessment of a wound, correct diagnosis and hence selection of an appropriate treatment is needed.
- In some aspects, the disclosure provides methods for determining the status of a wound by assessing the pH of a wound and/or wound exudate. Such wound pH information may be used to facilitate selection of the appropriate treatment to which the wound should be subjected.
- In some embodiments, the methods for determining the status of a wound disclosed herein comprise applying a dressing on a wound surface, wherein the dressing comprises a substrate material, and a pH sensitive dye composition disposed within the substrate material comprising at least one type of fruit or vegetable derived anthocyanin; and determining the status of the wound by assessing the color change of the pH sensitive dye after application of the dressing onto the wound surface. The color change of the pH sensitive dye provides information about the pH of the wound, and thus provides information as to the status (e.g., health) of the wound.
- In one embodiment, the pH of the wound is assessed on the basis of a change in the visual appearance of said substrate material. More specifically, the pH of the wound is assessed on the basis of the color of said substrate material. Assessing the color change of the pH sensitive dye composition comprises monitoring the color change of the dressing over time. Appropriate timing for monitoring the color change of the wound dressing may be determined by a healthcare professional or caregiver attending to the subject. For example, assessing the color change of the color of the pH sensitive dye composition may be performed by monitoring the color change of the dressing for a period between 1 to 24 hours, a period of between 2 to 16 hours, a period of between 3 to 12 hours, a period of between 4 to 10 hours, or a period of between 6 to 8 hours after application of the dressing onto the wound surface. In some embodiments, assessing the color change of the pH sensitive dye composition comprises monitoring the color change of the dressing at predetermined time intervals after application of the dressing onto the wound surface, i.e., at fifteen minute, thirty minute, one hour, two hour, four hour, six hour, eight hour, twelve hour or twenty hour time intervals after application of the dressing onto the wound surface.
- The color change of the pH sensitive dye can be monitored by visual inspection (e.g., visual inspection by the human eye) or with the aid of a color-sensing device. Color sensing devices include, for example, a colorimeter or spectrophotometer. Colorimeters and spectrophotometers are well-known in the art and are used to measure certain optical properties of various materials. In addition to colorimeters and spectrometers, the color change of the pH sensitive dye can be monitored using an imaging device, such a digital camera, a mobile phone, a smartphone, a tablet, a portable computer, a computer, and a scanner.
- Information on wound health aids healthcare professionals (e.g., a physician, physician assistant, pharmacist, nurse practitioner, nurse or case manager) and caregivers in determining the best treatment plan for a subject. In some embodiments, the method comprises assessing the color change of the pH sensitive dye after application of the dressing onto the wound surface; and, subsequently, carrying out another step in dependence upon the pH assessed. For example, the additional step can be advising a healthcare professional or caregiver to provide or select a treatment regimen for said wound, or advising a caregiver to remove/change/replace the wound dressing from the wound surface when the color of the wound dressing indicates a basic pH.
- The pH sensitive composition may serve as an indicator of bacterial growth in the wound through the change in color thereof (the pH will stay basic). Following evidence of bacterial growth in the wound, the wound can be cleaned, disinfected, and dressed with a sterile dressing immediately after a wearer is aware of it.
- The method may involve comparing the visual appearance, for example color, of the dressing with a reference means, for example a color reference means such as a color chart (or the like) to assess the pH of the dressing or environment.
- The dressing material may be arranged to enable pH information to be obtained directly from it without recourse to any external reference means. For example, said test material may incorporate a said reference means suitably arranged to enable pH information to be obtained directly from the test material.
- In some embodiments, the methods disclosed herein can include the step of recording information relating to the visual appearance (e.g., the color) of the substrate material. The color of the dressing may be recorded and/or the pH may be recorded. In yet another embodiment, the methods further comprise modifying the subject's clinical record to include information relating to the visual appearance (e.g., the color) of the wound dressing and the status of the wound. The clinical record may be stored in any suitable data storage medium (e.g., a computer readable medium).
- The invention is further described in the following examples, which do not limit the scope of the invention described in the claims.
- Experiments were conducted to evaluate the potential of anthocyanin in raspberries as a pH-sensitive dye. Raspberry juice (Rubus sp.) was mixed with an aluminum potassium sulfate mordant and processed, resulting in a dye that can be used to color cotton textiles. Cotton gauze bandages were dyed with this solution and wrapped around decomposing chicken, which had been treated with a range of pH values to simulate wound conditions. Changes in gauze color were observed by comparing RGB values before and after the bandages were exposed to the chicken. All bandages were sterilized in either an ethylene oxide machine or an autoclave before experimentation. The fabric was also detected Staphylococcus aureus in culture and could respond to pH changes more than once. The dye indicated pH and could safely be used on patients with long-term or chronic wounds to detect infection.
- A dye was made from raspberry juice and aluminum potassium sulfate. Cotton bandages were dyed and exposed to different pH levels as well as bacterial growth. Photographs were taken before and after the bandages were placed in different environments. The environments tested were pH values 5-9. Also, one group was exposed to bacterial growth on decomposing chicken. Red, green and blue values were extracted from the images using Adobe Photoshop Elements 11, and averaged to find before and after colors of each piece of cotton. The resulting color values were used to analyze the changes in color between each pH.
- As an initial experiment, the inventor sought to test the halochromic properties of raspberry juice. Organic raspberries were pureed in a food processor until a thick, smooth mixture resulted. Petri dishes were prepared containing solutions varying in pH from 3 to 11 using baking soda, acetic acid (5% aqueous solution), and water. Each solution also contained a magnesium source which influenced pH; milk of magnesia (Mg(OH)2) (CVS Brand, unflavored) was used in the basic solutions and magnesium citrate (MgO7C6H6) (CVS Brand, lemon flavored) was used in the acidic petri dishes. When 6.0 grams of raspberry juice were added to the solutions they displayed a gradient of colors, shown in
FIG. 1 . Acidic pH solutions turned the raspberry puree redder, and a neutral environment changes the puree to a purplish color. Basic environments resulted in a drastic transformation to a blue-green color. The apparent color changes provided evidence that the main pigment (anthocyanin) is halochromic, which enabled the next test to be conducted. - Raspberry juice does not fix naturally into cotton textiles, so two mordants were tested for their usefulness in attaching the juice to the fabric. Iron (III) oxide and aluminum potassium sulfate were selected as mordants. Each mordant was added to a solution consisting of equal parts water and raspberry puree and to a solution containing raspberry puree, water, and magnesium hydroxide (CVS Brand unflavored Milk of Magnesia).
- Pieces of fabric were placed in each of the four prepared solutions, and the solutions were heated to 65° C. The aluminum mordant without the added magnesium worked best, producing a bright red color like that of raspberry fruit. (
FIG. 2 ) The iron mordant without aluminum produced a duller, lighter red. Both pieces of fabric that were exposed to magnesium in solution did not dye evenly and resulted in spotted, uneven coloring. When exposed to different pH values, only the fabric dyed in an aluminum potassium sulfate solution without magnesium was capable of color change. This dye was selected as the optimum for dyeing fabric in future experiments. - In addition to dyeing fabric, attempts were made to extract a pigment from the dye for use in printing. The dye was concentrated by evaporating water and tested by writing with a quill. The aluminum potassium sulfate solution was tested with magnesium and without magnesium. The iron (III) oxide dye was not used in this testing due to the previous success of the aluminum potassium sulfate dye. The dyes were heated in test tubes in a beaker of water on a hot plate, and allowed to settle afterward. The solutions separated into different strata, but no solid pigment was available for extraction.
- Both solutions were then used as pen ink. The magnesium containing solution did not adhere to paper and resulted in a light lavender, barely visible stain. The dark red solution without magnesium stained the paper where applied and turned a dark purple upon contact with the paper. It is presumed that this was due to the high pH of paper. The solutions were then tested against commercial calligraphy ink by exposing them to water and observing any running or fading. The calligraphy ink showed no change and the produced dye showed minimal fading. A solid pigment could not be extracted easily, and the dye was not concentrated enough to be used as professional ink, so dyeing fabric was pursued further. In addition, there are more potential uses for halochromic fabric than halochromic ink.
- Varying pH was shown to affect the dye, so an experiment was designed to test the color changes of the fabric in conditions mimicking the environment produced by a skin wound. Unflavored gelatin (Knox Brand) was set in petri dishes to replicate the surface of human skin, and holes were poked into the gelatin with a sewing needle to imitate pores that would leak bodily fluid. Each sample was then brushed with a solution of a different pH, varying from 5 to 9. The mixtures were allowed to briefly soak into each of the artificial pores, but some solution still remained on the surface of the gelatin. The pH solutions were produced with household items: lemon and lime juice were used to acidify pH values, water was used to neutralize pH values, and baking soda was used to alkalize pH values. A piece of sterilized gauze (CVS Brand) was then laid on the top of the gelatin in each petri dish. Four gauze samples were tested in each pH: two samples that had been previously soaked in acetic acid and two samples that had been previously rinsed in water. Before the samples were tested, they were sterilized in an ethylene oxide machine. The newly sterilized bandage squares were left on petri dishes of varying pH values for approximately 15 minutes to fully absorb the solution. After the allotted time, each piece was placed onto a white sheet of paper and photographed with a camera (Nikon D3100).
- Color changes were observed and photographed, and numerical color values were extracted using Adobe Photoshop Elements 11. Each image was uploaded into the program and the brightness levels in the image were regulated. The color of the white paper surrounding the bandage in the photograph was set to be equal to absolute white in the image. This leveling process adjusted all of the colors accordingly, providing consistency between the colors in the images when they were all edited in this way. Next, each bandage was divided into squares and the Red-Green-Blue (“RGB”) value of all of the pixels in each square was averaged. The RGB values of these squares were used for statistical testing.
- Bacterial growth conditions were tested to determine if the dyed fabric could be used to signal bacterial infection by changing color when in contact with infected areas. First, 4 pieces of raw chicken (Purdue chicken breasts) were basted with solutions with
pH 5 throughpH 9. Then, strips of medical gauze dyed with the aluminum potassium sulfate dye were placed on pieces of chicken. The samples were each sealed in individual bags (Ziploc sandwich bags) and left in a residential garage for three days. The chicken was purposefully left to decompose to see what color changes the gauze would undergo in the presence of bacterial growth. - All 4 samples changed from their original color to the same shade of light blue when they were exposed to the microbial colonies. This color change began to occur during day 1 and day 2 of exposure to the chicken, as the bacteria began to grow. On the morning of the 3rd day, each gauze sample was photographed. The photographs were then uploaded to Adobe Photoshop Elements 11, where the RGB values of each pixel of the fabric were averaged and recorded. The resulting numbers were used in data analysis.
- The dyed fabric was exposed to S. aureus in petri dishes. The cultures were obtained from a laboratory at Becker College and remained in the laboratory and sealed for the duration of the observation. Before exposure to the bacteria, the bandages were dyed and rinsed in water to remove excess dye, resulting in a purple color. They were also autoclaved to before being exposed to the cultures to prevent outside contamination. The purple bandages were laid on top of S. aureus in petri dishes and observed after a two-day growth period. Photographs of the bandages were taken at this time to access color change. The bacterial colonies were autoclaved and discarded by a professional biohazard disposal company.
- The data shows a clear relationship between pH and color. In the first test, the dyed fabric was rinsed with water to remove all extra dye. Specifically, two pieces of dyed, sterilized cotton bandage were washed in water and soaked in each
pH 5 to 9 on top of gelatin to simulate skin conditions. Photos were taken before the pH was changed and afterward, and RGB values were obtained from these images and are recorded above. The photographs taken of the fabric after this process all show similar RGB values, shown by the low standard deviations (STDEV R=3.66, G=0.79, B=3.72) of each color value. When each square of fabric was exposed to the neutral pH of water,pH 7, the sections of bandage all displayed a similar color, which was violet. This color can be observed inFIG. 3 , and in the RGB values in Table 1.FIG. 4 shows the blue RGB values obtained were plotted against the red RGB values before and after pH soaking. Each line represents a pH, connecting the initial Red-Blue point, noted in black, to the final Red-Blue point. In each fabric square, green is the lowest value and is not predominantly seen in the images. The blue value is the highest, followed by red, which combine to make the bluish purple seen in the fabric. -
TABLE 1 Before Before Before After After After pH R G B R G B 5.0 167.0 151.5 197.5 186.0 136.5 172.0 6.0 173.0 152.0 200.5 179.0 147.0 214.5 7.0 172.0 152.5 200.0 160.0 165.5 210.0 8.0 167.5 151.0 194.0 125.5 127.0 150.5 9.0 175.5 153.0 204.0 138.5 138.5 156.0 STDEV 3.7 0.8 3.7 25.8 14.5 30.0 - After this information was obtained, two bandage pieces were exposed to each of the pH values ranging from 5-9, inclusive. The photographs taken after this exposure show a much larger variance in color. Each RGB value was correlated to the pH, and there were large differences among them (STDEV R=25.81, G=14.50, B=29.99). Although each piece of fabric began at relatively the same color, different pH levels in each environment lead to varying colors. The color the fabric produced at each pH was also consistent. As seen by the similarities in the two sample groups (Appendix A), each pH caused a reliable color change. Exposing different cotton bandages dyed with the same dye to the same pH values used in this experiment would result in very similar RGB values. To ensure the results of this experiment were not by chance, an ANOVA test was run on the percent differences of both the red and blue values. An ANOVA was run on these values because they show that the Red-Blue color change, in comparison with the original values, was different in each environment. The test shows that this result is extremely unlikely to be achieved by random chance and that the data was statistically significant (p=8.45*10−27).
- In the second experiment, the dyed fabric was rinsed with acetic acid before being exposed to varying pH values. Specifically, two pieces of dyed, sterilized cotton bandage were rinsed in acetic acid and then soaked in each
pH 5 to 9 on top of gelatin to simulate skin conditions. Photos were taken before the pH was changed and afterward, and RGB values were obtained from these images and are recorded in the chart above. The acetic acid rinse was done to simulate the application of acetic acid to a wound, which is done to lower pH and promote healing. The starting RGB values for each separate bandage square obtained from images taken after the acetic acid rinse were very similar (STDEV R=3.65, G=1.85, B=2.56), showing that each bandage began at approximately the same color (Table 2,FIG. 5 ). This color was light pink, seen in the overall high RGB values that add brightness and the elevation of the Red value above the other two. -
TABLE 2 Before Before Before After After After pH R G B R G B 5.0 242.0 189.0 203.5 218.5 161.0 166.0 6.0 250.0 191.0 204.0 212.5 151.5 151.0 7.0 246.0 194.0 204.0 222.5 200.0 195.0 8.0 251.0 191.5 208.5 127.5 125.5 118.5 9.0 249.0 192.5 201.5 151.5 147.5 142.5 STDEV 3.7 1.9 2.6 43.9 27.3 28.4 - Despite starting at a very low pH (2 to 3), the fabric responded to environmental changes in pH and retained its halochromic properties. Two separate fabric sections were exposed to
pH values 5 through 9 as in the previous test. The two samples in each environment were similar colors after testing (data not shown), showing the consistency of the color change. The colors resulting from the environments were very different (STDEV R=43.88, G=27.28, B=28.39)(Table 2). This shows that color changed drastically in the presence of unique pH values. To test if this result could be obtained by chance, an ANOVA was run on the distance between the percent differences of each color, as was done in the previous experiment. These numbers were chosen for the ANOVA because they represent the total Red-Blue color change for each pH compared with the original color. It can be said with confidence that the results show a color change that could not be achieved randomly and was statistically significant (p=4.62*10−44). The bandages continued to respond to environmental pH changes even after they had been rinsed in acetic acid. - The color change after the acetic acid rinse followed the same gradient as the color change after the water rinse in the first experiment. Bandages in basic environments of pH 8-9 had lower RGB values overall resulting in a darker color and similar red and blue values, which give a blue-purple shade. Cotton pieces in
neutral pH 7 had generally high RGB values, making them a lighter purple than the bandages in basic environments. The gauze in acidic environments of pH 5-6 displayed higher Red values compared to almost all of the other trials, giving them a more reddish hue than any of the other samples. - The dyed gauze also showed a response to pH changes due to bacterial contamination. Cotton pieces were presoaked in each pH ranging from 5 to 9 and exposed to decomposing chicken. Before exposure to microbial populations, each square of fabric varied in RGB value (STDEV R=44.22, G=17.88, B=15.73), because each was a different color. After exposure to bacteria, the RGB values were much more similar between initial pH groups (STDEV R=13.20, G=10.49, B=11.28) (Table 3,
FIG. 6 ). All of the Red, Green, and Blue values of the five samples increased, showing a consistently lighter color in the fabric when bacteria were present. Microbial contamination usually causes wound pH to become more basic, and the data collected also show this trend. The fabric squares in the previous experiment that were exposed to basic pH values exhibited a blue color, and the fabric in this experiment did the same. The Blue values are consistently higher than the Red values, showing that the basic environment produced by bacteria again resulted in a blue hue. -
TABLE 3 Before Before Before After After After pH R G B R G B 5 188 141 155 216 241 238 6 192 158 169 209 220 225 7 111 122 156 233 243 249 8 108 116 130 198 247 253 9 109 119 137 222 239 248 STDEV 44.2 17.9 15.7 13.2 10.5 11.3 - The fabric was also exposed to a specific type of bacteria, Staphylococcus Aureus. The fabric was sterilized in an autoclave before exposure to the bacteria to ensure no outside contamination would occur. The fabric began at a purple color after being rinsed in water, shown in Table 4.
-
TABLE 4 Before Colors After Color R G B R G B 196 175 221 172.33 183.67 189.67 197 194 219
Two shades of purple, which had high red and blue values, were used as starting colors: one from light rinsing in water with some excess dye still remaining and the other from a complete water rinse removing all unfixed dye. Both beginning colors turned into the same final color after the fabric was exposed to S. aureus. Three bandage samples were exposed to different S. aureus colonies in different petri dishes and the average RGB values were obtained from photographs of each sample. These values are in Table 4. This color change is significant because it shows that the fabric will indicate the presence of S. aureus with a color change to a bluish grey. The color change in the presence of this type of bacteria is consistent regardless of starting color, as shown by the starting color variations leading to the same final color. The fabric responded as was predicted because bacteria often create high pH environments, which would result in a bluish grey color similar to the final color of previous experiments. The dyed cotton gauze responded to changes in environmental pH in each test performed. - The data gathered in this experiment supported the hypothesis; the pH of an environment has an effect on the color of gauze dyed with a solution derived from raspberry juice. The color change follows a red to purple to blue gradient in accordance with pH as it changes from acidic to neutral to basic. The results of this project show that the raspberry dye made is halochromic and reusable, meaning it can react to changing pH more than once. Also, the dyed fabric can be easily sterilized using preexisting machinery, and it is still responsive to pH changes afterward. This includes environmental pH changes caused by bacteria, such as S. aureus, and other sources.
- The experiments completed in this study provide strong evidence for the potential of halochromic gauze for use in the medical industry. Patients with long-term wounds such as lower extremity ulcers caused by diabetes could monitor their wounds at home with more certainty if they knew the pH of their wounds and the possible causes of pH changes. Color change was shown to be easily detectable in the fabric, and a layperson could observe the variations in color without outside assistance. This would provide more information about the health, stage of healing, and presence of infection in a wound to both the patient and the caretaker. The dyed gauze could also be used for patients who are advised to keep their bandages on for extended periods of time, such as a person wearing an Unna's boot. The fabric could also be used on patients with burns in order to learn more about the health of their wounds without removing the bandage, which is often a very painful process. In addition, the dyed gauze was sterilized successfully in both an autoclave and an ethylene oxide machine, showing it could be sterilized with existing equipment.
- To be helpful to hospital patients with closely monitored wounds or people who are monitoring long-term wounds without professional assistance, the dyed cotton fabric used in this experiment could be made into smaller products for home use. This could help the layperson identify infection in small wounds and cuts. Overall, the cotton bandages in this experiment would be helpful in monitoring the state of any injury leaking bodily fluid.
-
- Gethin, G. (2007). The significance of surface pH in chronic wounds. Wounds uK, 3(3), 52.
- Leveen H, et al., (1973) Chemical acidification of wounds. An adjuvant to healing and the unfavourable action of alkalinity and ammonia. Ann Surgery 178(6): 745-50.
- Van der Schueren, L., & De Clerck, K. (2012). Coloration and application of ph-sensitive dyes on textile materials. Coloration Technology, 128, 82-90.
- Glover, B. J., & Martin, C. (2012). Anthocyanins. Current Biology, 22(5), R147-R150.
- Romanelli, M, et al., (2002) Technological Advances in Wound Bed Measurements, Wounds. 14(2).
- It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/690,784 US20200085991A1 (en) | 2014-10-15 | 2019-11-21 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/514,579 US9855364B2 (en) | 2014-10-15 | 2014-10-15 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
US15/830,188 US10517981B2 (en) | 2014-10-15 | 2017-12-04 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
US16/690,784 US20200085991A1 (en) | 2014-10-15 | 2019-11-21 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/830,188 Division US10517981B2 (en) | 2014-10-15 | 2017-12-04 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200085991A1 true US20200085991A1 (en) | 2020-03-19 |
Family
ID=55748178
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/514,579 Active US9855364B2 (en) | 2014-10-15 | 2014-10-15 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
US15/830,188 Active 2035-05-01 US10517981B2 (en) | 2014-10-15 | 2017-12-04 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
US16/690,784 Abandoned US20200085991A1 (en) | 2014-10-15 | 2019-11-21 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/514,579 Active US9855364B2 (en) | 2014-10-15 | 2014-10-15 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
US15/830,188 Active 2035-05-01 US10517981B2 (en) | 2014-10-15 | 2017-12-04 | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources |
Country Status (1)
Country | Link |
---|---|
US (3) | US9855364B2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11116884B2 (en) | 2010-12-08 | 2021-09-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
US11135315B2 (en) | 2010-11-30 | 2021-10-05 | Convatec Technologies Inc. | Composition for detecting biofilms on viable tissues |
US11241339B2 (en) | 2011-11-29 | 2022-02-08 | Convatec Inc. | Perforated binder for laminated wound dressing |
US11241525B2 (en) | 2010-12-08 | 2022-02-08 | Convatec Technologies Inc. | Wound exudate monitor accessory |
US11266774B2 (en) | 2016-07-08 | 2022-03-08 | Convatec Technologies Inc. | Fluid collection apparatus |
US11286601B2 (en) | 2012-12-20 | 2022-03-29 | Convatec Technologies, Inc. | Processing of chemically modified cellulosic fibres |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11452808B2 (en) | 2016-07-08 | 2022-09-27 | Convatec Technologies Inc. | Fluid flow sensing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US11583430B2 (en) | 2011-09-02 | 2023-02-21 | Convatec Ltd. | Skin contact material |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
US11628093B2 (en) | 2008-05-08 | 2023-04-18 | Convatec Technologies, Inc. | Wound dressing |
US11723808B2 (en) | 2016-03-30 | 2023-08-15 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
US11740241B2 (en) | 2016-03-30 | 2023-08-29 | Synovo Gmbh | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106178073A (en) * | 2016-08-24 | 2016-12-07 | 广东中科国丝生物科技有限公司 | A kind of bandage that can automatically point out wound inflammation |
US10066914B2 (en) * | 2016-09-09 | 2018-09-04 | Deane Owen Elliott | Disposable arrow wipe with chemical indicator |
IT201700000360A1 (en) * | 2017-01-03 | 2018-07-03 | Martina Mantelli | Gauze for use in surgery |
CN106948189A (en) * | 2017-04-14 | 2017-07-14 | 山西大学 | A kind of hospital gauze that function is indicated with pH |
US11236234B2 (en) | 2018-01-03 | 2022-02-01 | United States Gypsum Company | Joint compounds and plasters with a complexometric dye and methods |
US11698344B2 (en) | 2018-09-05 | 2023-07-11 | University Of South Carolina | PH indicator swabs for biomonitoring and diagnostics |
US11471335B2 (en) | 2018-09-05 | 2022-10-18 | University Of South Carolina | Gel-within-gel wound dressing |
CN110237295B (en) * | 2019-07-29 | 2021-08-24 | 健诺维(成都)生物科技有限公司 | Anthocyanin alginate dressing |
WO2021091234A1 (en) * | 2019-11-04 | 2021-05-14 | 한국생산기술연구원 | Ph-sensitive fiber structure for skin care, and preparation method therefor |
CN111359003B (en) * | 2020-03-30 | 2020-12-29 | 安庆市康明纳包装有限公司 | Orthopedic wound antibacterial protective film and preparation method thereof |
CN112998395A (en) * | 2021-04-22 | 2021-06-22 | 宁波翘楚智能设备科技有限公司 | Liftable table |
CN113171309B (en) * | 2021-05-19 | 2022-08-12 | 成都农业科技中心 | Whitening and moisturizing cosmetic composition containing phloretin as well as preparation and application thereof |
CN114432485A (en) * | 2022-02-15 | 2022-05-06 | 周建大 | pH-responsive quaternary ammonium salt antibacterial dressing and preparation method thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020015726A1 (en) * | 2000-06-30 | 2002-02-07 | Scamilla Aledo Maria Aparecida De Carvalho | Dressings and bandages comprising same |
US7183455B2 (en) * | 2002-08-27 | 2007-02-27 | Drdc Limited | Adhesive dressing |
WO2004072182A2 (en) * | 2003-01-15 | 2004-08-26 | Arun Mohanlal Baid | A novel method of dyeing the textile article from medicinally rich herbs |
KR20050105461A (en) * | 2003-02-13 | 2005-11-04 | 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 | SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF α,α-TREHALOSE |
CN1624236A (en) * | 2003-12-01 | 2005-06-08 | 金子隆 | Method of dyeing fiber, fiber dyed, dye and drier for use in dye production |
US7112714B2 (en) * | 2004-11-01 | 2006-09-26 | Leber Claudia K | Topical wound dressing and method of making same |
KR20090009202A (en) * | 2006-03-17 | 2009-01-22 | 허발사이언스 싱가포르 피티이 리미티드 | Extractions and methods comprising elder species |
WO2009059218A1 (en) * | 2007-10-31 | 2009-05-07 | Phytomedics, Inc. | Berry preparations for treatment of diabetes and metabolic syndrome |
US20130046264A1 (en) * | 2008-11-10 | 2013-02-21 | Nurman Salim | Skin patch for absorbing toxins from the body |
TWI491414B (en) * | 2011-05-25 | 2015-07-11 | Taiwan Textile Res Inst | Skin caring product with indicating function and method of using the same |
-
2014
- 2014-10-15 US US14/514,579 patent/US9855364B2/en active Active
-
2017
- 2017-12-04 US US15/830,188 patent/US10517981B2/en active Active
-
2019
- 2019-11-21 US US16/690,784 patent/US20200085991A1/en not_active Abandoned
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11628093B2 (en) | 2008-05-08 | 2023-04-18 | Convatec Technologies, Inc. | Wound dressing |
US11458044B2 (en) | 2008-09-29 | 2022-10-04 | Convatec Technologies Inc. | Wound dressing |
US11135315B2 (en) | 2010-11-30 | 2021-10-05 | Convatec Technologies Inc. | Composition for detecting biofilms on viable tissues |
US11241525B2 (en) | 2010-12-08 | 2022-02-08 | Convatec Technologies Inc. | Wound exudate monitor accessory |
US11116884B2 (en) | 2010-12-08 | 2021-09-14 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
US11583430B2 (en) | 2011-09-02 | 2023-02-21 | Convatec Ltd. | Skin contact material |
US11241339B2 (en) | 2011-11-29 | 2022-02-08 | Convatec Inc. | Perforated binder for laminated wound dressing |
US11286601B2 (en) | 2012-12-20 | 2022-03-29 | Convatec Technologies, Inc. | Processing of chemically modified cellulosic fibres |
US11723808B2 (en) | 2016-03-30 | 2023-08-15 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
US11740241B2 (en) | 2016-03-30 | 2023-08-29 | Synovo Gmbh | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds |
US11452808B2 (en) | 2016-07-08 | 2022-09-27 | Convatec Technologies Inc. | Fluid flow sensing |
US11266774B2 (en) | 2016-07-08 | 2022-03-08 | Convatec Technologies Inc. | Fluid collection apparatus |
US11596554B2 (en) | 2016-07-08 | 2023-03-07 | Convatec Technologies Inc. | Flexible negative pressure system |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
Also Published As
Publication number | Publication date |
---|---|
US10517981B2 (en) | 2019-12-31 |
US20160106880A1 (en) | 2016-04-21 |
US20180093007A1 (en) | 2018-04-05 |
US9855364B2 (en) | 2018-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10517981B2 (en) | Wound dressing materials incorporating anthocyanins derived from fruit or vegetable sources | |
Mama et al. | Antibacterial activity of honey against methicillin-resistant staphylococcus aureus: a laboratory-based experimental study | |
US20230296528A1 (en) | pH INDICATOR SWABS FOR BIOMONITORING AND DIAGNOSTICS | |
KR101807885B1 (en) | Silver Oxide Formulations Having Improved Whiteness Characteristics | |
JP2010512739A (en) | Skin coating containing microbial indicator | |
CN108478518A (en) | A kind of composition and the acne-eliminating cosmetic containing the composition | |
CN110078794A (en) | A kind of antibacterial peptide and its application | |
CN111150876B (en) | Drug resistance visualized band-aid and preparation method thereof | |
CN108578279A (en) | A kind of application of skin care compositions and methods | |
Saff et al. | Apocrine Chromhidrosis Involving the Areolae in a 15‐ear‐Old Amateur Figure Skater | |
Chukwueze et al. | Isolation and identification of bacteria from surgical wound attention at Enugu State University Teaching Hospital, Enugu | |
CN104013760B (en) | Myogenic rubine collagen sponge medicine and preparation method and application | |
CN110478131B (en) | Gauze with pH response color change, preparation method thereof and application of gauze | |
CN103054839A (en) | Medicine for killing acid-fast staining positive (red) bacilli | |
CN106265719A (en) | A kind of medical heat clearing away anti-bacterial hydrogel eye sticker and preparation method thereof | |
CN107576653B (en) | Composition for identifying amniotic fluid of pregnant woman | |
US20220323615A1 (en) | Solvatochromic indicator for detecting infection | |
Naimat et al. | Formulation and evaluation of feminine wash for candidiasis with the extraction of Piper betle as antifungal effect | |
Shah et al. | Susceptibility pattern of pathogenic bacteria “Pseudomonas aeruginosa” to various antibiotics isolated from post-surgical wound of diabetic patient at Hayatabad Medical Complex (HMC) Peshawar: susceptibility pattern of pathogenic bacteria “Pseudomonas aeruginosa” | |
TWI736995B (en) | Novel small molecule compounds and their uses | |
RU2697407C1 (en) | Method for controlling hands treatment with antiseptics | |
Silva et al. | Effects of Brazilian green propolis glycolic solutions against bacterial biofilm on elastomers used in maxillofacial prostheses | |
Janani et al. | Bioactivity of Textile Fabrics Impregnated with Crude Extract of Biden Pilosa Plant Species | |
Roberts | VALUE OF METHYLENE BLUE-GENTIAN VIOLET 5 PER CENT. IN PREOPERATIVE SKIN PREPARATION | |
Sibbald et al. | Wound Bed Preparation 2006: Increased Bacterial Burden and Infection—The Story of NERDS© and STONES© |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: DUKAL CORPORATION, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:COOMBER, ALLISON;REEL/FRAME:056228/0842 Effective date: 20210511 |
|
AS | Assignment |
Owner name: DUKAL, LLC, NEW YORK Free format text: ENTITY CONVERSION AND NAME CHANGE;ASSIGNOR:DUKAL INC.;REEL/FRAME:057337/0094 Effective date: 20210823 Owner name: DUKAL INC., NEW YORK Free format text: MERGER AND CHANGE OF NAME;ASSIGNORS:DUKAL CORPORATION;DUKAL INC.;REEL/FRAME:057312/0236 Effective date: 20210722 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |